Introduction {#s1}
============

Macro-autophagy (hereafter autophagy) is a conserved pathway for the delivery of cytoplasmic material into the lysosomal system for degradation ([@bib32]). Upon induction of autophagy, double membrane organelles termed autophagosomes are formed in a de novo manner. Initially, autophagosome precursors appear as small membrane structures referred to as isolation membranes (or phagophores). As isolation membranes expand, they gradually enclose cytoplasmic cargo material. Upon closure of the isolation membranes, autophagosomes are formed within which the cargo is isolated from the rest of the cytoplasm. Autophagosomes subsequently fuse with the lysosomal compartment where the inner membrane and the cargo are eventually degraded.

When induced by starvation autophagy can be relatively non-selective with regard to the cargo that is sequestered within autophagosomes. However, it has become clear that autophagy can be highly selective and even exclusive when induced by the presence of intracellular cargo material ([@bib67]). Substances including aggregated proteins, cytosolic pathogens and damaged or surplus organelles have all been shown to be selectively degraded by autophagy ([@bib24]). Autophagy thereby protects the organism from pathological conditions such as neurodegeneration, cancer and infection ([@bib36]; [@bib39]). In *S. cerevisiae* the cytoplasm-to-vacuole-targeting (Cvt) pathway mediates the delivery of the oligomeric prApe1 enzyme as well as Ams1 and Ape4 into the vacuole via small autophagosomes that are referred to as Cvt vesicles ([@bib43]).

Selectivity of autophagic processes is mediated by cargo receptors that link the cargo to isolation membranes due to their ability to simultaneously bind the cargo and Atg8-family proteins on the isolation membrane ([@bib20]; [@bib53]; [@bib60]). The interaction of the cargo receptors with Atg8-family proteins is mediated by LC3-interacting regions (LIRs) ([@bib49][@bib19]) also known as Atg8 interacting motifs (AIMs) in the cargo receptors ([@bib48]). Atg8-family proteins are ubiquitin-like proteins that are conjugated to the headgroup of the membrane lipid phosphatidylethanolamine (PE) rendering the otherwise soluble proteins membrane-bound ([@bib18]). This conjugation reaction is also referred to as lipidation. The Atg8 conjugation cascade is analogous to the chain of reactions that mediate the conjugation of ubiquitin to its substrates. Thus, Atg8 is activated by the E1-like enzyme Atg7 under consumption of ATP and subsequently transferred to the E2-like enzyme Atg3 from which Atg8 is ultimately transferred to the headgroup of PE ([@bib18]; [@bib27]). This last step is strongly facilitated by a complex composed of the Atg12\~Atg5 protein conjugate and Atg16. The Atg12\~Atg5-Atg16 complex acts in an E3-like manner and determines the site of Atg8 conjugation ([@bib15]; [@bib16]). The Atg8 conjugation machinery acts in concert with other proteins of the autophagic machinery including the Atg1/ULK1 complex, the class III PI3K complex 1, Atg9 and the WIPIs to mediate the efficient generation of autophagosomes or Cvt vesicles ([@bib10]; [@bib14]; [@bib21]; [@bib26]; [@bib29]; [@bib31]; [@bib41], [@bib42]; [@bib59]). The precise mechanisms by which the Atg12\~Atg5-Atg16 complex and Atg8 aid the formation, elongation or closure of the autophagosomal membranes are unclear.

Recent work has provided important information about how the presence of an autophagic cargo induces the formation of an isolation membrane. In particular, it was shown that the Atg19 cargo receptor recruits the Atg11 scaffold protein to the prApe1 cargo for Atg1 kinase activation ([@bib22]; [@bib62]). In addition, it was demonstrated that the cargo receptors Optineurin and NDP52 recruit the ULK1 complex to damaged mitochondria ([@bib35]). Furthermore, TRIM proteins were shown to localize the ULK1, PI3K complexes and ATG16L1 to their cargo in a process referred to as precision autophagy ([@bib8]; [@bib25]).

A major question is how the presence of an autophagic cargo is coupled to Atg8 conjugation and thus isolation membrane formation in space and time. Here we show that the *S. cerevisiae* Atg19 and Atg34 as well as the human p62, Optineurin and NDP52 cargo receptors interact with the E3-like Atg12\~Atg5-Atg16 complex. Employing Atg19 as a model in a fully reconstituted system we show that it is capable of recruiting Atg12\~Atg5-Atg16 to the prApe1 cargo. This recruitment is mediated by a direct interaction of the AIM motifs in Atg19 with the Atg5 subunit. In our in vitro system the recruitment of the Atg12\~Atg5-Atg16 complex is sufficient to drive accumulation of lipidated Atg8 at the cargo. Since the interaction of the Atg19 cargo receptor with the E3-like Atg12\~Atg5-Atg16 complex is outcompeted by Atg8, the system may have an inherent directionality whereby the final product in form of Atg8\~PE could displace the upstream conjugation machinery at the concave side of the isolation membrane.

Results {#s2}
=======

During classical ubiquitination reactions the localization of the E3 ligase determines where ubiquitin is conjugated to its substrates ([@bib9]; [@bib28]). We therefore asked if autophagic cargo receptors could interact with the Atg12\~Atg5-Atg16 E3-like complex and thereby recruit it to the cargo. Indeed, in pull down experiments GST-Atg19 used as a bait successfully pulled down Atg12\~Atg5-Atg16, demonstrating a direct interaction between these two components ([Figure 1A](#fig1){ref-type="fig"}). In a complementary approach we imaged the recruitment of Atg12\~Atg5-Atg16-mCherry to beads coated with GST-Atg19 under equilibrium condition ([Figure 1B](#fig1){ref-type="fig"}). Atg12\~Atg5-Atg16-mCherry was robustly and specifically recruited to these beads ([Figure 1B](#fig1){ref-type="fig"}). The α-mannosidase (Ams1) receptor Atg34 was also able to bind the Atg12\~Atg5-Atg16 complex ([Figure 1C](#fig1){ref-type="fig"}), suggesting that this interaction is a more general property of cargo receptors. In order to test if this interaction occurs in cells we performed immunoprecipitation experiments using Atg5-TAP to pull down 6xmyc-Atg19 ([Figure 1D](#fig1){ref-type="fig"}). Atg19 was specifically pulled down by Atg5-TAP. Employing the M-Track assay, which is based on the methylation of the human histone 3 N-terminus by the human SUV39H1 methyltransferase when the two components come into close contact ([@bib7]; [@bib69]), we confirmed that Atg19 and the Atg12\~Atg5-Atg16 complex are in close proximity in living cells ([Figure 1E](#fig1){ref-type="fig"}). It was previously shown that overexpression of a methyltransferase does not result in unspecific methylation of the histone 3 N-terminus ([@bib7]). Next, we tested if the interaction of cargo receptors with the E3-like complex is conserved. To this end, we co-expressed human GFP-ATG5 and mCherry-p62 in HeLa cells in which the endogenous p62 had been knocked-down by RNAi. mCherry-p62 was efficiently co-precipitated by GFP-ATG5 ([Figure 1F](#fig1){ref-type="fig"}). We confirmed this result by using a microscopy-based assay in which we imaged the recruitment of mCherry-p62 to GFP-ATG5 coated beads in HeLa cell lysates ([Figure 1G](#fig1){ref-type="fig"}). We extended this analysis by investigating other human cargo receptors and found that NDP52 was also pulled down by GFP-ATG5 ([Figure 1H](#fig1){ref-type="fig"}). In addition, we detected a weak but consistent co-precipitation of Optineurin (OPTN) ([Figure 1H](#fig1){ref-type="fig"}). In summary, the *S. cerevisiae* Atg19 and Atg34 cargo receptors directly interact with the Atg12\~Atg5-Atg16 E3-like enzyme and an interaction with this complex is also detectable for the human cargo receptors p62, OPTN and NDP52.10.7554/eLife.18544.003Figure 1.Cargo receptors interact with the Atg12\~Atg5-Atg16 complex in vitro and in vivo.(**A**) Western blots of GST-pull down experiments using GST-Atg19 as bait and the Atg12\~Atg5-Atg16 complex as prey. Degradation bands of GST-Atg19 are marked with an asterisk (\*). (**B**) Glutathione Sepharose beads were coated with GST-Atg19 or GST and imaged in the presence of the Atg12\~Atg5-Atg16-mCherry complex at equilibrium. The quantification shows the relative mCherry signal intensity measured at the bead in percent. Three independent experiments were considered for quantification. Scale bar: 100 µm. (**C**) Same assay as shown in (**A**) but using GST-Atg34 as a bait. (**D**) Western blots of a co-immunoprecipitation experiment using *atg19Δ, atg8∆ S. cerevisiae* cells with integrated Atg5-TAP and transformed with 6xmyc-Atg19. Atg5-TAP was precipitated using magnetic Epoxy IgG-beads. (**E**) M-Track assay using Protein A-Histone 3 (H3)-tagged Atg16 and Atg19 fused to 9xmyc and the SUV39H1 methyl-transferase (HKMT). Shown is a Western blot with an anti-trimethylation-specific antibody to assess the methylation signal and anti-ProteinA to assess the amount of cleaved protein A-H3 on beads. The Atg13 interaction with Atg17 was used as a positive control for the assay. (**F**) Co-immunoprecipitation experiment using GFP-TRAP beads incubated with lysates from HeLa cells transfected with the indicated expression constructs. Endogenous p62 was down regulated by RNAi. (**G**) Lysates from HeLa cells transfected with GFP and mCherry-p62 or GFP-ATG5 and mCherry-p62 were incubated with GFP-TRAP beads and the recruitment of the proteins to the beads was imaged by spinning disc microscopy. The graph shows the average and standard deviation over all beads from one experiment. The endogenous p62 was downregulated by RNAi. (**H**) Western blot analysis of lysates from HeLa cells co-transfected with the indicated constructs and subjected to anti-GFP immunoprecipitation (GFP-TRAP, Chromotek). Numbers below each blot indicate the relative band intensity for the particular blots shown. The beads/input enrichment factors (EF) indicate the fold of enrichment of each mCherry-tagged cargo receptor in the GFP-ATG5 beads fraction over its correspondent GFP control, normalized on the input levels and equalized to the GAPDH blots. Representative blots of at least four independent experiments are shown (left). The plot shows the average sample/control fold enrichment in the indicated fractions for each cargo receptor. The beads/input enrichment factor is defined as above. Averages and standard deviations of at least four independent experiments are shown (right).**DOI:** [http://dx.doi.org/10.7554/eLife.18544.003](10.7554/eLife.18544.003)10.7554/eLife.18544.004Figure 1---figure supplement 1.Human ATG5 pulls down p62 from cell lysates.Anti-GFP blot of the GFP-TRAP experiment shown in [Figure 1F](#fig1){ref-type="fig"}. Shown are input and bead fractions.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.004](10.7554/eLife.18544.004)

Further focusing on Atg19, we tested which of the Atg12\~Atg5-Atg16 complex subunits interacts with the Atg19 cargo receptor by using GST-Atg19 as bait to pull down Atg5 stabilized with the N-terminal helix of Atg16 (Atg5-Atg16 (1--46)), the Atg12\~Atg5 conjugate, the Atg5-Atg16 complex and the full Atg12\~Atg5-Atg16 complex ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). Atg12 could not be tested in isolation since we were unable to purify the protein. All proteins tested showed interaction with Atg19 suggesting that Atg5 is sufficient for the binding to Atg19 ([Figure 2A,B](#fig2){ref-type="fig"}). We confirmed this result in size exclusion chromatography experiments using Atg5-Atg16 (1--46) and Atg19. Indeed, a fraction of Atg5-Atg16 (1--46) shifted to higher molecular weight fractions in the presence of Atg19 ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).10.7554/eLife.18544.005Figure 2.Atg19 directly binds Atg5 via its C-terminal domain and requires its coiled-coil domain to interact with the Atg12\~Atg5-Atg16 complex.(**A**) GST-pull down experiment using GST-Atg19 or GST as bait in the presence of recombinant Atg5-Atg16 (1--46), Atg12\~Atg5, Atg5-Atg16 or Atg12\~Atg5-Atg16 complexes as preys. Input and bead fractions were loaded on a SDS-PAGE gel and subjected to Western blotting. Proteins were detected using an anti-Atg5 antibody. See also [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}. (**B**) Quantification of GST-pull down experiments, one of which is shown in (**A**). The amount of pulled down protein for the Atg12\~Atg5-Atg16 complex was set to 100%. Average values were calculated from three independent experiments and plotted in the histogram together with the standard deviations. (**C**) GST-pull down experiment using GST-Atg19 or GST as bait and recombinant Atg16-meGFP or the Atg12\~Atg5-Atg16-meGFP complex as prey. Input and bead samples were loaded on a SDS-PAGE gel and subjected to Western blotting. Proteins were detected using an anti-GFP antibody. See also [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}. (**D**) Schematic representation of the Atg19 domain organization. N-terminal domain (NTD, residues 1--124), coiled-coil domain (CC, residues 124--254), Ams1 binding domain (ABD, residue 254--365) and C-terminal domain (CTD, residues 365--415). (**E**) The Atg12\~Atg5-Atg16 complex and its subunits, Atg5-Atg16 (1--46), Atg5-Atg16 and the Atg12\~Atg5 conjugate were incubated with either full length GST-Atg19 or truncated versions thereof as baits and the pulled down protein was detected by Western blotting using an anti-Atg5 antibody. The bead fractions showing GST-labeled Atg19 and truncated versions thereof are depicted in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}. (**F**) Glutathione beads coated with full length GST-Atg19 or truncations thereof were incubated with the Atg12\~Atg5-Atg16-mCherry complex and its recruitment to the beads was determined by spinning disc microscopy. A quantification of three independent experiments is shown to the left. The signal measured for binding to GST-Atg19 full length was set to 100%. (**G**) Glutathione beads were coated with Atg19 full length (GST-Atg19), Atg19 C-terminal domain (GST-Atg19(365--415)) or Atg19 lacking the C-terminal canonical AIM motif (GST-Atg19(1--407)) and incubated with Atg12\~Atg5-Atg16-mCherry. A quantification of three independent experiments is shown to the left. The signal measured for binding to GST-Atg19 full length was set to 100%.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.005](10.7554/eLife.18544.005)10.7554/eLife.18544.006Figure 2---figure supplement 1.Atg19 and Atg5 interact in solution.Atg19 and Atg5-Atg16 (1--46) were co-incubated at concentrations of 580 µM and run on a Superose 6 size exclusion column. Aliquots of individual fractions were run on SDS-PAGE gels and Coomassie stained (top panel). Size exclusion chromatography fractions of individual Atg5-Atg16 (1--46) (middle panel) and Atg19 (bottom panel) proteins run at 55 µM concentration.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.006](10.7554/eLife.18544.006)10.7554/eLife.18544.007Figure 2---figure supplement 2.Mapping Atg19 interaction with Atg12\~Atg5-Atg16 complex.(**A**) Ponceau staining of input samples of pull down experiment shown in [Figure 2A](#fig2){ref-type="fig"}. (**B**) Ponceau staining of input and bead samples of pull down experiment shown in [Figure 2C](#fig2){ref-type="fig"}. (**C**) Coomassie stained gels of GST-labeled Atg19 and truncated versions thereof used for the pull down experiments shown in [Figure 2E](#fig2){ref-type="fig"}. Each panel represents final bead fractions after incubation with the indicated prey proteins.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.007](10.7554/eLife.18544.007)

The presence of Atg16 had a stimulatory effect on the interaction of Atg5 with Atg19 suggesting that Atg16 could directly interact with Atg19 ([Figure 2A,B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). However, when tested in isolation Atg16 did not show any detectable binding to Atg19 ([Figure 2C](#fig2){ref-type="fig"}). Full length Atg16 may therefore enhance the interaction by an allosteric effect on Atg5 or by increasing the avidity of the interaction due to its ability to self-associate ([@bib13]; [@bib23]).

In order to identify the regions in Atg19 that are required for the interaction with Atg12\~Atg5-Atg16 we tested a series of Atg19 truncation mutants ([Figure 2D](#fig2){ref-type="fig"}) for their interaction with the entire complex and components thereof ([Figure 2E](#fig2){ref-type="fig"}). Atg5 and Atg5-Atg16 showed robust interaction with all Atg19 truncations including the C-terminal domain encompassing amino acids 365--415 ([Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). The presence of Atg12, either in context of the Atg12\~Atg5 conjugate or the Atg12\~Atg5-Atg16 complex, changed the properties of the interaction and required the presence of amino acids 124--254, which include the cargo binding domain of Atg19 ([@bib66]). We corroborated the results of the pull down experiments for the full Atg12\~Atg5-Atg16 complex in a microscopy-based assay under equilibrium conditions ([Figure 2F](#fig2){ref-type="fig"}). This assay confirmed that the coiled-coil domain of Atg19 is required for the interaction when Atg5 is conjugated to Atg12 ([Figure 2F](#fig2){ref-type="fig"}). To interrogate the role of the C-terminal region of Atg19 we performed further microscopy-based interaction experiments ([Figure 2G](#fig2){ref-type="fig"}). Consistent with the pull down experiments the Atg12\~Atg5-Atg16 complex bound strongly to full length Atg19 but not to the isolated C-terminus (amino acids 365--415) (compare [Figure 2E and G](#fig2){ref-type="fig"}) . Intriguingly, deletion of the last eight amino acids containing the canonical AIM motif ([@bib47]; [@bib56]) from the C-terminus of Atg19 strongly reduced the interaction ([Figure 3A](#fig3){ref-type="fig"}) suggesting that this AIM motif contributes to the interaction of Atg19 with the Atg12\~Atg5-Atg16 complex. Next, we further dissected the contribution of the AIM motifs in the Atg19 C-terminus to the interaction with Atg5. While deletion of the canonical AIM motif in the extreme C-terminus resulted in strong but incomplete reduction in Atg5 binding, further mutation of two additional AIM-like sequences ([@bib1]; [@bib56]) completely abolished the interaction ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3C](#fig3){ref-type="fig"} [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The AIM-dependent association of Atg19 with Atg5 is relevant for the interaction of the two proteins in vivo as the W412A mutation in the canonical AIM motif of Atg19 results in markedly reduced interaction of the two proteins in co-immunoprecipitation experiments ([Figure 3D](#fig3){ref-type="fig"}).10.7554/eLife.18544.008Figure 3.The AIM motifs in the C-terminal domain of Atg19 are required for its interaction with Atg5 and are competitively bound by Atg8.(**A**) Amino acid sequence of the C-terminal domain (365-415) of Atg19 containing the canonical AIM motif (^412^WEEL^415^) and two AIM-like motifs (^376^FYSF^379^, ^384^LPEL^387^). (**B**) Glutathione beads coated with the indicated proteins were imaged in the presence of Atg5-mCherry-Atg16 (1--46) complex under equilibrium conditions. The mCherry signal is shown in false color (ImageJ: Fire). See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. (**C**) Quantification of three independent experiments of the relative mCherry signal intensity measured at the bead. Due to optical reasons very low signals at the beads resulted in values lower than the background and thus negative values. Error bars represent standard deviations. (**D**) Co-immunoprecipitation experiment of 6xmyc-Atg19 or 6xmyc-Atg19W412A with Atg5-TAP as bait in *S. cerevisiae* cell lysates. Western blots of bead and lysate fractions are shown. Atg12\~Atg5-TAP was detected with an anti-TAP and 6xmyc-Atg19 with an anti-Myc antibody. A quantification of three independent experiments is shown to the right. Shown are averages and standard deviations. (**E**) Glutathione beads coated with the GST-Atg19 C-terminus (365-415) or GST were imaged in the presence of Atg5-mCherry-Atg16 (1--46) complex under equilibrium conditions. For the competition experiment recombinant GFP-Atg8 (or buffer) was added to the sample at a final concentration corresponding to 1x initial concentration of Atg5-mCherry-Atg16 (1--46). Purified Atg8 (or buffer) was added to a final concentration of 22x the initial concentration of Atg5-mCherry-Atg16 (1--46)). Representative microscopy pictures are shown. (**F**) Quantification of three independent experiments, one of which is shown in (**E**). The mCherry intensity in the '+ buffer' sample were GST-Atg19(365--415) was used as bait was set to 100%. Due to optical reasons very low signals at the beads resulted in values lower than the background and thus negative values. Bars represent standard deviations. (**G**) Glutathione Sepharose beads were coated with GST-prApe1(1--41) and Atg19 or GST and imaged in the presence of the Atg12\~Atg5-Atg16-mCherry complex. Subsequently, recombinant GFP-Atg8 was added to the sample at a final concentration corresponding to 1x or 10x the initial concentration of the Atg12\~Atg5-Atg16-mCherry complex. The binding of the complex to the beads in the absence of Atg8 was set to 100%. The histogram shows the averaged values of three independent experiments and the error bars represent standard deviations. N = 3 for the prApe1 samples. See also [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.008](10.7554/eLife.18544.008)10.7554/eLife.18544.009Figure 3---figure supplement 1.AIM-dependent interaction of the Atg19 C-terminal domain with Atg5.Western blot of a GST-pull down experiment employing GST fusions of the wild type Atg19 CTD (365-415) or the indicated mutants as baits and Atg5-Atg16 (1--46) as prey. Bead samples were subjected to Western blotting using an anti-Atg5 antibody for detection (bead samples, upper panel) or Coomassie staining (input samples, lower panel), respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.009](10.7554/eLife.18544.009)10.7554/eLife.18544.010Figure 3---figure supplement 2.Recruitment of Atg19 and Atg12\~Atg5-Atg16 to cargo mimetic beads.Representative pictures and experimental scheme of mCherry-Atg19 recruitment to cargo mimetic beads coated with GST-prApe1(1--45) in (**A**) and Atg12\~Atg5-Atg16-eGFP to beads in the presence or absence of Atg19 in (**B**). A quantification of three independent experiments is shown in (**B**).**DOI:** [http://dx.doi.org/10.7554/eLife.18544.010](10.7554/eLife.18544.010)

The dependence of the Atg19 - Atg12\~Atg5-Atg16 interaction on the AIM motifs suggested that it is mutually exclusive with the interaction of Atg19 with Atg8. To test this possibility, we immobilized the C-terminus of Atg19 on beads and added Atg5-mCherry-Atg16 (1--46). Subsequently, we added GFP-Atg8 or Atg8 to the beads and determined the signal of Atg5-mCherry-Atg16 (1--46) on the beads ([Figure 3E](#fig3){ref-type="fig"}). Indeed, Atg8 outcompeted the Atg19-bound Atg5-mCherry-Atg16 (1--46) in a dose dependent manner. The loss of the Atg5-mCherry signal correlated with an increased GFP-Atg8 signal at the bead ([Figure 3E,F](#fig3){ref-type="fig"}). Thus, the interaction of Atg5 with the C-terminus of Atg19 is AIM-dependent and mutually exclusive with Atg8 binding. Next, we asked if the interaction of Atg19 with Atg5 is also mutually exclusive with the Atg19 - Atg8 interaction in the context of the entire Atg12\~Atg5-Atg16 complex and when Atg19 is bound to the prApe1 cargo. First, we generated cargo mimetic beads by attaching the prApe1 propeptide to them via a GST-tag. Consistent with previous results Atg19 was robustly recruited to these beads ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}) ([@bib51]; [@bib56]). Next we tested if Atg19 recruited the Atg12\~Atg5-Atg16 complex to the artificial cargo. Indeed, the Atg12\~Atg5-Atg16 complex showed a strong Atg19 dependent signal at the beads ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). Employing this experimental setup, we then went on by adding GFP-Atg8 to the cargo mimetic beads ([Figure 3G](#fig3){ref-type="fig"}). The complex was displaced in a concentration dependent manner confirming that Atg12\~Atg5-Atg16 and Atg8 compete for the same binding sites on Atg19.

The Atg5 subunit of the Atg12\~Atg5-Atg16 complex and the AIM-like motifs in Atg19 are both essential for the binding of these two components. Moreover, the interaction of Atg19 with Atg5 and Atg8 is mutually exclusive, strongly suggesting that the AIM motifs in Atg19 directly interact with Atg5. To identify potential binding sites in Atg5 for the AIM motif we employed computational modeling and molecular dynamics simulations. To this end, we used the structure of Atg5-Atg16 (1--46) from *S. cerevisiae* (PDB:2DYO) ([@bib38]) and performed molecular dynamics simulations which allowed us to capture the flexibility of the Atg5-Atg16 (1--46) complex. Subsequently, in silico docking was performed for 10 randomly selected snapshots from the molecular dynamics trajectory using a peptide encompassing the canonical AIM motif (^411^TWEEL^415^) of Atg19. Modelling analysis suggested three possible binding sites for the peptide, two of which mapped to Atg5 ([Figure 4A,B](#fig4){ref-type="fig"}) and one to a site formed by Atg16. Since our pull down experiments ([Figure 2C](#fig2){ref-type="fig"}) did not detect any direct interaction of Atg16 with Atg19 the latter site was excluded from further analysis. The other two sites were analyzed. Both contained residues that were persistently involved in forming salt bridges and/or hydrogen bonds with the TWEEL peptide. These were K57 and K137 in the first binding site ([Figure 4A](#fig4){ref-type="fig"}, pose 1) and N84 and R208 in the second binding site ([Figure 4A](#fig4){ref-type="fig"}, pose 2). These two sites show a similar architecture composed of a hydrophobic pocket surrounded by positively charged residues. Specifically, molecular dynamics simulations showed that the hydrophobic pocket serves to dock W412 and L415 of the TWEEL peptide, while lysine, arginine and asparagine residues on the surface of Atg5 contact the peptide via salt bridges and hydrogen bonds with the glutamic acid residues E413 and E414. Structural superposition showed that the two sites are unrelated to the AIM-binding sites of Atg8 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).10.7554/eLife.18544.011Figure 4.Structure of the Atg5-Atg16 (1--46) complex with the predicted binding sites for the TWEEL peptide.(**A**) Structure of Atg5 in complex with the N-terminus of Atg16 (PDB:2DYO, \[[@bib38]\]). The backbone of Atg5 is shown in green and Atg16 is shown in orange. The position of the predicted TWEEL pentapeptide binding sites on Atg5 are shown in blue (pose 1 and 2). The residues predicted to contact the glutamates of the TWEEL peptide are shown as sticks. (**B**) Surface representation of the Atg12\~Atg5-Atg16 (1--46) complex (PDB:3W1S \[[@bib46]\]). The amino acids in the potential TWEEL binding sites predicted to contact the glutamates of the peptide are shown in blue. Atg5 is shown in grey, Atg12 is shown in violet and Atg16 is shown in orange. (**C**) Representative blots of GST-pull down experiments conducted with GST-Atg19 or GST in the presence of Atg5-Atg16 (1--46) wild type and its single mutant versions (K57E, N84E, K137E and R208E) are shown. Input and bead samples were subjected to Western blot analysis. GST-fusion bait proteins were detected with Ponceau Staining (lower row) and prey proteins were detected with an anti-Atg5 antibody (upper row).**DOI:** [http://dx.doi.org/10.7554/eLife.18544.011](10.7554/eLife.18544.011)10.7554/eLife.18544.012Figure 4---figure supplement 1.Structural relationship between the Atg5 and Atg8 AIM binding sites.Shown is the structure of Atg5 (blue) in complex with the N-terminus of Atg16 (yellow) (PDB: 2DYO, \[[@bib38]\]). The canonical AIM motif of Atg19 (^412^WEEL^415^) ([@bib47]) is shown in green and is located at the positions it would occupy if the binding mode was analogous to its binding to Atg8. The Atg8 K57 and K137 in pose 1 as well as N84 and R208 in pose 2 are shown in red.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.012](10.7554/eLife.18544.012)

In order to validate the predictions from the molecular dynamics simulations we set out to interfere with the interaction. To this end, we mutated the predicted binding sites in Atg5 at residues K57, K137, N84 or R208 to E. We refrained from mutating the hydrophobic pockets of Atg5 in order to avoid non-specific loss of function effects due to disruption of the hydrophobic core of the protein. The mutant proteins were tested for their ability to bind to full length GST-Atg19 in pull down experiments ([Figure 4C](#fig4){ref-type="fig"}). Atg5 K137E as well as Atg5 R208E still efficiently bound to Atg19, while the Atg5 K57E and Atg5 N84E mutants showed no detectable binding in this assay.

We went on to test the effect of the K57E and N84E mutations on the recruitment of the Atg12\~Atg5-Atg16 complex to cargo mimetic beads ([Figure 5A--C](#fig5){ref-type="fig"}). The wild type Atg12\~Atg5-Atg16-mCherry complex robustly localized to the beads. Introduction of the K57E into Atg5 resulted in a strongly reduced recruitment of the Atg12\~Atg5-Atg16 complex, while the N84E mutation rendered the recruitment undetectable ([Figure 5B,C](#fig5){ref-type="fig"}). When combined, the two mutations also resulted in a loss of Atg12\~Atg5-Atg16-mCherry complex recruitment to the beads. Thus, introducing negative charge at positions 57 and 84 in the two predicted AIM binding sites interfered with the interaction of the two proteins. These residues are therefore likely to be directly involved in the formation of binding sites for the AIM motif. Interestingly, in the context of the Atg12\~Atg5 conjugate N84 in pose two would be largely covered by Atg12 ([Figure 4B](#fig4){ref-type="fig"}). This may explain why the C-terminal domain of Atg19 containing the AIM motif is not sufficient for the interaction with Atg12\~Atg5 and requires the coiled-coil domain ([Figure 2D--G](#fig2){ref-type="fig"}), which may reorient Atg12 away from pose 2.10.7554/eLife.18544.013Figure 5.Mutation of the predicted binding sites for Atg19 in Atg5 impairs the recruitment of the Atg12\~Atg5-Atg16 complex to cargo mimetic beads and Cvt pathway function but does not affect bulk autophagy.(**A**) Coomassie stained gels showing the input amounts of the Atg12\~Atg5-Atg16-mCherry complex (upper gel) and of the GST-prApe1(1--41) + Atg19 or GST proteins on the beads (lower gel) used for the experiment shown in (**B**). (**B**) GST-prApe1(1--41) + Atg19 or GST coated glutathione beads imaged in the presence of Atg12\~Atg5-Atg16-mCherry complex (wild type, K57E, N84E or K57E,N84E). (**C**) Quantification of three independent experiments of the relative mCherry signal intensity measured at the beads. One experiment used for the quantification is shown in (**B**). The signal measured for the wild type Atg5\~Atg12-Atg16-mCherry complex was set to 100%. Due to optical reasons very low signals at the beads resulted in values lower than the background and thus negative values. Error bars represent standard deviations. (**D**) Coomassie-stained gel showing the result of a liposome co-sedimentation assay using wild type Atg12\~Atg5-Atg16-mCherry and the indicated point mutants thereof. Liposome binding allows the protein to be pelleted (P). The unbound protein remains in the supernatant (S). (**E**) Quantification of in vitro Atg8 conjugation assays using the indicated mutants of Atg12\~Atg5. The amount of conjugated Atg8 and un-conjugated Atg8 was measured as the band intensity signal on a Coomassie stained gel and set as 100%. Amounts of conjugated Atg8 were determined relative to this. Averages of these values were calculated from three independent experiments and the final values are plotted together with standard deviations. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. (**F**) Co-immunoprecipitation using Atg5-TAP or Atg5 K57E,N84E-TAP as bait in the presence of 6xmyc-Atg19 and either Atg16 wild type or Atg16 E102A. 6xmyc-Atg19 pulled down protein in wild type Atg5 and Atg16 expressing samples was set to 100. All the other conditions were quantified in relation to this (Atg5 wild type and Atg16 E102A, 85% (±59) p-value = 0.63, n.s.; Atg5 K57E,N84E and Atg16 wild type, 13% (±12.9) p-value \< 0.0001; Atg5 K57E,N84E and Atg16 E102A, 2.9% (±4.6) p-value \< 0.0001). The p-values were calculated using a two-tailed Student t-test. Proteins were detected using anti-TAP and anti-Myc antibodies, anti-Pgk1 was used as loading control. Shown is a representative blot of three experiments. (**G**) prApe1 processing assay using an *atg5Δ* strain transformed with the indicated expression constructs. The lower Ape1 band indicates prApe1 processing and thus its delivery into the vacuole. The prApe1 and Ape1 bands were detected with an anti-Ape1 antibody. The expression levels of Atg5 were visualised with an anti-Myc antibody. The Pgk1 signal served as a loading control. The bar graph to the right shows a quantification of six independent experiments. The p-values were calculated using a two-tailed Student t-test. (**H**) prApe1 processing assay using yeast *atg16Δ* strain with Atg5 wild type-TAP or Atg5 K57E,N84E-TAP stably integrated in the genome and transformed with the indicated Atg16 constructs. The blot shows the prApe1 processing in the Atg5 mutants in combination with Atg16 wild type in rich conditions (the full set of tested Atg16 can be found in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). A blot showing the full set of Atg16 mutants after 6 hr nitrogen-starvation is shown in [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}. The Ape1 bands were detected using an anti-Ape1 antibody. The bar graph shows quantification of the prApe1 processing of four independent experiments. The p-value was calculated using a two-tailed Student t-test. (**I**) A representative blot of a GFP-Atg8 cleavage assay is shown. (**J**) Pho8∆60-activity assay under rich (black bars) and 5 hr N-starvation (white bars) growing conditions using a *pho13∆, pho8∆60*, *atg5Δ* strain transformed with the indicated Atg5 expression constructs or an empty vector. At least three independent experiments were conducted and the mean values for each conditions were plotted. The error bars represent the standard deviation.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.013](10.7554/eLife.18544.013)10.7554/eLife.18544.014Figure 5---figure supplement 1.The K57E and N84E mutations do not impair the ability of the Atg12\~Atg5 conjugate to promote Atg8 conjugation.In vitro Atg8 lipidation reaction using SUVs and wild type as well the indicated Atg12\~Atg5 mutants. Shown are Coomassie stained gels of a time series of Atg8 conjugation reactions in the presence of Atg12\~Atg5 K57E or N84E (left panel) and wild type or K57E,N84E mutant (right panel). The Atg12\~Atg5 band is not visible on the gel at the concentrations used in this experiment. The Atg8\~PE is detected as a faster migrating band in a urea containing gel.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.014](10.7554/eLife.18544.014)10.7554/eLife.18544.015Figure 5---figure supplement 2.Effect of the disruption of the Atg16 -- Atg21 interaction on prApe1 processing.prApe1 processing assay in *atg16Δ* yeast strain expressing transiently transformed Atg16 D101A or E102A or D101A,E102A-double mutant proteins and Atg5-TAP or Atg5 K57E,N84E-TAP stably integrated in the genome (complete blot from [Figure 5H](#fig5){ref-type="fig"} upper blot). The Atg5 K57E,N84E-TAP in combination with Atg16 wild type shows reduced prApe1 processing. This mutant, in combination with Atg16 D101A,E102A and D101A,E102A-double mutation, shows fully arrested prApe1 processing. Atg5 expression levels were checked using anti-TAP-antibody; Pgk1 served as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.015](10.7554/eLife.18544.015)10.7554/eLife.18544.016Figure 5---figure supplement 3.The Cvt pathway is affected upon disrupting Atg19 -- Atg5 interaction.(**A**) prApe1 processing assay using yeast *atg16Δ* strain with Atg5-TAP or Atg5 K57E,N84E-TAP stably integrated in the genome and transformed with the indicated Atg16 constructs. The blot shows the full set of Atg16 mutants after 6 hr nitrogen-starvation. The Ape1 bands were detected using anti-Ape1 antibody. The bar graph in (**B**) shows quantification of the prApe1 processing of four independent experiments. The p-value was calculated using a two-tailed Student t-test.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.016](10.7554/eLife.18544.016)10.7554/eLife.18544.017Figure 5---figure supplement 4.Mutation of the predicted binding sites for Atg19 in Atg5 does not affect bulk autophagy.Pho8∆60-activity assay under rich (black bars) and 5 hr N-starvation (white bars) growing conditions using a *pho13∆, pho8∆60*, *atg16∆,* Atg5-TAP or Atg5 K57E,N84E-TAP strain transformed with the indicated Atg16 expression constructs or an empty vector. Three independent experiments were conducted and the mean values for each conditions were plotted. The error bars represent the standard deviation. No significant difference was observed between the wild type Atg5 and the Atg5 K57E,N84E mutant.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.017](10.7554/eLife.18544.017)

The K57 and N84 mutations did not abolish the conjugation of Atg5 to Atg12 ([Figure 5A](#fig5){ref-type="fig"}). We also did not observe significant defects of the mutant Atg12\~Atg5-Atg16 complexes with respect to liposome binding ([Figure 5D](#fig5){ref-type="fig"}) or of the single and double mutant Atg12\~Atg5 conjugates with respect to promoting Atg8 lipidation ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

We went on to test if the K57E,N84E double mutation would interfere with the Atg5 - Atg19 interaction in vivo by performing co-immunoprecipitations ([Figure 5F](#fig5){ref-type="fig"}). Consistent with the results shown above ([Figure 3D](#fig3){ref-type="fig"}), wild type Atg5 robustly co-precipitated Atg19. The K57E,N84E double mutant Atg5 showed a strongly reduced ability to interact with Atg19, but the interaction was still detectable ([Figure 5F](#fig5){ref-type="fig"}). It was previously shown that Atg16 interacts with Atg21 and that this interaction recruits the Atg12\~Atg5-Atg16 complex to the pre-autophagosomal structure (PAS) ([@bib21]). We therefore asked if the residual interaction of the K57E,N84E mutant Atg5 with Atg19 could be dependent on the recruitment of the Atg12\~Atg5-Atg16 complex to the PAS by Atg21. To this end, we introduced the E102A mutation into Atg16, which was reported to abolish the Atg16 - Atg21 interaction ([@bib21]). Indeed, the interaction of the Atg5 K57E,N84E with Atg19 became undetectable in context of the Atg16 E102A mutation ([Figure 5F](#fig5){ref-type="fig"}).

Next, we tested the impact of the single mutations or their combination on the functionality of the Cvt pathway by monitoring prApe1 processing. The N84E mutation, which had the stronger effect on the Atg19 - Atg5 interaction also affected prApe1 processing more pronouncedly compared to the K57E mutation while the K57E,N84E double mutation had the strongest effect on prApe1 processing ([Figure 5G,H](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). For the cells expressing Atg5-TAP ([Figure 5H](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) we consistently noticed a somewhat lower levels of the Atg12\~Atg5 for the K57E,N84E double mutant under rich conditions. This effect was not seen for the myc-tagged version. prApe1 processing was also affected by the K57E,N84E double mutation under starvation condition in the context of the Atg16 D101A, E102A mutation ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"} [Figure 5H](#fig5){ref-type="fig"}). In contrast, starvation-induced bulk autophagy as measured by GFP-Atg8 cleavage and the Pho8∆60 assay was not significantly affected by the Atg5 K57E,N84E double mutation ([Figure 5I,J](#fig5){ref-type="fig"}), even when tested in combination with the Atg16 D101A, E102A mutant ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}).

The data presented so far have shown that the Atg19 cargo receptor can recruit the E3-like Atg12\~Atg5-Atg16 complex to the prApe1 cargo and that mutations that abolish this interaction reduce the efficiency of the Cvt pathway. The cargo receptor - E3 interaction might therefore be a minimal axis to couple Atg8 conjugation to the cargo. To test this hypothesis, we developed a fully reconstituted system to recapitulate these reactions. In analogy to the experiment shown in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}, we added the Atg12\~Atg5-Atg16 complex to cargo mimetic beads bound by Atg19. The Atg12\~Atg5-Atg16 complex directly binds to membranes ([Figure 5D](#fig5){ref-type="fig"}) ([@bib54]) and it may thus be able to link membranes and the cargo. To test this, we added small unilamellar vesicles (SUVs) labeled by the incorporation of ATTO390-PE or Rhodamine to Atg19-bound cargo mimetic beads in the presence or absence of the Atg12\~Atg5-Atg16 complex ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The SUVs were recruited to the beads in an Atg12\~Atg5-Atg16 complex dependent manner ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The complexes containing the Atg19 binding defective mutants of Atg5 were less efficiently recruited to cargo mimetic beads and were also less efficient in membrane recruitment ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Thus, the complex brings the membrane substrate for Atg8 conjugation in proximity of the cargo. Next we analyzed if this minimal system would allow local accumulation of conjugated Atg8 by adding the ubiquitin-like molecule GFP-Atg8, the E1-like enzyme Atg7, the E2-like enzyme Atg3, and the cofactors MgCl~2~ and ATP to the system. Intriguingly, GFP-Atg8 showed increased signal at the cargo in the presence of ATP ([Figure 6A](#fig6){ref-type="fig"}). We also detected an increased signal for the membrane and the Atg12\~Atg5-Atg16 complex ([Figure 6A](#fig6){ref-type="fig"}), likely due to its association with Atg8 and the membranes ([@bib23]; [@bib54]). Since the presence of ATP increased the GFP-Atg8 signal at the beads, this effect may be due to lipidation of Atg8 and thus its stable anchoring and concentration on the membranes. If so, then the lipidated Atg8 should be more strongly bound by the Atg19 receptor ([@bib1]; [@bib56]). To test this, we conducted FRAP experiments on the cargo mimetic beads ([Figure 6B](#fig6){ref-type="fig"}). Indeed, Atg8 recovered more slowly in the presence of ATP and recovery was slowest for the Atg8 positive puncta, which we interpret as larger Atg8-positive vesicular structures ([Figure 6B](#fig6){ref-type="fig"}).10.7554/eLife.18544.018Figure 6.In vitro reconstitution of cargo-directed Atg8 lipidation.(**A**) GST-prApe1(1--45) + Atg19 ± Atg12\~Atg5-Atg16-mCherry coated Sepharose beads were imaged in the presence of ATTO390-containing SUVs and GFP-Atg8∆R117, Atg7, Atg3, MgCl~2~ with or without ATP. Representative pictures and the experimental scheme are shown. The images corresponding to the mCherry channel are displayed in false color (ImageJ: Fire). See also [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}. (**B**) Representative pictures of a GFP-Atg8 FRAP experiment conducted on the surface of GST-prApe1(1--45) + Atg19 + Atg12\~Atg5-Atg16-mCherry coated Sepharose beads after the conjugation reaction performed in the presence (lower row) or absence (upper row) of ATP. The graph shows the quantification of the GFP signal measured on the surface of at least two beads per condition (Cx: Atg12\~Atg5-Atg16-mCherry). (**C**) Representative pictures, experimental scheme and quantification of Atg8 lipidation on cargo mimetic beads coated with GST-prApe1(1--45) + Atg19 + Atg12\~Atg5-Atg16-mCherry + ATTO390-containing SUVs in the presence of the conjugation machinery (Atg7, Atg3, GFP-Atg8∆R117, MgCl~2~, ±ATP) after removal of SUVs from the solution by washing. (**D**) Representative pictures of a GFP-Atg8 FRAP experiment conducted on the surface of GST-prApe1(1--45) + Atg19 + Atg12\~Atg5-Atg16-mCherry + ATTO390-containing SUVs-coated Sepharose beads, after conjugation reaction performed in the presence (lower row) or absence (upper row) of ATP. The graph shows the quantification of the recovered GFP signal on the beads in the presence or absence of ATP, respectively, for at least two beads per condition. See also [Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.018](10.7554/eLife.18544.018)10.7554/eLife.18544.019Figure 6---figure supplement 1.Atg19 AIM-dependent recruitment of the Atg12\~Atg5-Atg16 complex and vesicles to cargo mimetic beads.Representative pictures and experimental scheme of Rhodamine-SUV recruitment to cargo mimetic beads coated with GST-prApe1(1--45) and Atg19 (wild type or AIM mutant (F376A, F379A, P385A, E386A, W412A)) with or without the Atg12\~Atg5-Atg16-meGFP complex.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.019](10.7554/eLife.18544.019)10.7554/eLife.18544.020Figure 6---figure supplement 2.Vesicle recruitment by Atg12\~Atg5-Atg16 mutants to cargo mimetic beads.Representative pictures and quantification of Atg12\~Atg5-Atg16-mCherry and ATTO390-SUVs recruitment to cargo mimetic beads coated with GST-prApe1(1--45) and Atg19. The quantification is based on three independent experiments and the bars indicate the standard deviation. Signal corresponding to wild type Atg12\~Atg5-Atg16 was set to 100%.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.020](10.7554/eLife.18544.020)10.7554/eLife.18544.021Figure 6---figure supplement 3.De-conjugation of lipidated Atg8 on the beads.(**A**) Quantification of three independent experiments performed using cargo mimetic beads prepared as in [Figure 6A](#fig6){ref-type="fig"}. Atg4 was added to cargo mimetic beads after an overnight conjugation reaction. The GFP-Atg8∆R117 signal at the beads was measured after 30 min of de-conjugation reaction. (**B**) Representative images of the Atg4 de-conjugation of Atg8 at the beads at the indicated time points.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.021](10.7554/eLife.18544.021)

In the experiments shown in [Figure 6A,B](#fig6){ref-type="fig"} the vesicles were also present in solution and we could therefore not exclude the possibility that conjugation occurred remotely from the cargo, followed by attachment of the vesicles harboring lipidated Atg8. For this reason, we recruited vesicles to cargo mimetic beads via the Atg12\~Atg5-Atg16 complex and washed away unbound vesicles ([Figure 6C](#fig6){ref-type="fig"}). Subsequently, we added the Atg8 conjugation machinery. In the presence of ATP the bead associated signal was increased, consistent with local lipidation of Atg8 at the cargo ([Figure 6C](#fig6){ref-type="fig"}). To corroborate this result, we performed FRAP experiments on these beads ([Figure 6D](#fig6){ref-type="fig"}). Indeed, the recovery of Atg8 was much reduced in the presence of ATP, consistent with its stable attachment to the membrane via lipidation. Furthermore, upon addition of the Atg4 protein, which removes Atg8 from PE the GFP-Atg8 signal decreased ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}).

Discussion {#s3}
==========

Here we have shown that the cargo receptor Atg19 directly interacts with the Atg5 subunit of the E3-like Atg12\~Atg5-Atg16 complex and that this interaction is sufficient to direct Atg8 conjugation to the cargo in a reconstituted system. The recruitment of the Atg12\~Atg5-Atg16 complex requires the AIM motifs of Atg19 and it is likely that these motifs directly bind Atg5 since our modeling analysis and molecular dynamics simulations predicted two binding sites for the C-terminal AIM motif of Atg19 and mutation of these sites abolished Atg19 binding. In addition, the interaction of Atg19 with Atg5 is competitive with the interaction with Atg8, which also directly interacts with the C-terminal AIM motif of Atg19 ([@bib47]). Additional regulation of the two mutually exclusive binding events may occur due to phosphorylation as it was shown that Atg19 is phosphorylated in its C-terminal domain ([@bib51]; [@bib61]).

Since Atg19 contains multiple AIM-like sequences, it is possible that both sites in Atg5 contribute to Atg19 binding. Mutation of N84 in site two had a more pronounced effect on the interaction with Atg19. In the context of the Atg12\~Atg5 conjugate this site would be buried by the Atg12 subunit ([@bib46]). Since the coiled-coil domain of Atg19 was required for the interaction of Atg19 with Atg5 when conjugated to Atg12, we hypothesize that the coiled-coil domain is required to expose binding site two by changing the position of Atg12.

The interaction of cargo receptors with the Atg12\~Atg5-Atg16 complex is conserved since we detected an interaction of the *S. cerevisiae* Atg34 and human p62, NDP52 and Optineurin cargo receptors with Atg12\~Atg5-Atg16 and ATG5, respectively, suggesting that the recruitment of the E3-like ligase for ATG8-family members conjugation to the cargo is a more general property of cargo receptors. Future work will have to elucidate the biochemical details of the interaction of the human cargo receptors with ATG5 and the ATG12\~ATG5-ATG16L complex. It is possible that this interaction is at least for p62 in part mediated indirectly by ALFY since it interacts with p62 and ATG5 ([@bib12]). A similar mechanism has been described for *C. elegans* where EPG-7 binds both, p62/SQST-1 and ATG12/LGG-3 ([@bib37]).

The results presented in this study suggest the following sequence of events, at least for the Cvt pathway ([Figure 7](#fig7){ref-type="fig"}). When bound to their respective cargo, cargo receptors cluster and provide a high-avidity binding platform that recruits the autophagy machinery, including the E3-like Atg12\~Atg5-Atg16 complex. This machinery is able to bring and keep membranes in close proximity to the cargo and to act catalytically by promoting several rounds of Atg8 conjugation. Consistent with the idea of local Atg8 lipidation the E2-like Atg3 enzyme localizes to the site of autophagosome formation ([@bib45]). The Atg12\~Atg5-Atg16 complex is able to directly bind lipids ([@bib54]) and thus it may link the cargo to the membrane. However, in vivo additional interactions with PROPPINs/WIPIs will render the system more robust ([@bib10]; [@bib21]).10.7554/eLife.18544.022Figure 7.Model for the molecular mechanism of cargo-directed Atg8 lipidation.The Atg19 cargo receptor binds the cargo (1) and recruits the E3-like Atg12\~Atg5-Atg16 complex to the cargo via its AIM motifs (2). In the presence of a membrane source, Atg8 is locally conjugated (3) and may eventually outcompete the Atg12\~Atg5-Atg16 complex from Atg19 binding. At the same time the AIM motifs of Atg19 may keep the Atg8-coated isolation membrane close to the cargo excluding non-cargo material from incorporation into selective autophagosomes (4). See main text for extended discussion.**DOI:** [http://dx.doi.org/10.7554/eLife.18544.022](10.7554/eLife.18544.022)

Due to the action of the Atg8 conjugation machinery Atg8 accumulates at the isolation membrane and may subsequently outcompete the Atg12\~Atg5-Atg16 complex on the concave side of the isolation membrane. In conflict with this hypothesis is the finding that the signal of the Atg12\~Atg5-Atg16 complex at the bead was not decreased upon addition of ATP ([Figure 6C](#fig6){ref-type="fig"}). We interpret this result with the previously described interactions of the Atg12\~Atg5-Atg16 complex with the membrane and lipidated Atg8 on the convex side ([@bib23]; [@bib54]). Consistent with exclusion of Atg12\~Atg5-Atg16 from the concave side of the isolation membrane, the Atg12\~Atg5-Atg16 complex is excluded from the autophagosomal lumen in vivo ([@bib40]). On the concave side Atg8 may be subsequently bound with high avidity by the cargo receptors, which could result in close apposition of the membrane and the cargo and thus exclusion of non-cargo material from the autophagosome ([Figure 7](#fig7){ref-type="fig"}) ([@bib1]; [@bib56]; [@bib65]). As a consequence, this mechanism would localize the Atg8 conjugation machinery to the highly curved edge of the membrane where the isolation membrane has not yet formed, which may additionally stimulate Atg8 conjugation ([@bib44]). Thus, the intricate AIM/LIR-based interplay between the cargo, the cargo receptors, the Atg8 conjugation machinery and Atg8 may serve to confer directionality to the Atg8 lipidation resulting in robust membrane growth exclusively around the cargo. In vivo, this may occur at a permissive site such as the vacuole or the endoplasmic reticulum ([@bib34]; [@bib43]).

Materials and methods {#s4}
=====================

Accession numbers {#s4-1}
-----------------

Atg3: NP_014404; Atg4: NP_014176.2; Atg5: NP_015176.1; Atg7: NP_012041.1; Atg8 NP_009475.1; Atg10: NP_013058.1; Atg12: NP_009776.1; Atg16: NP_013882.1; Atg19: NP_014559.1; Atg34: NP_014558.1; prApe1: NP_012819; p62/SQSTM1: NP_003891; NDP52: AAA75297.1; OPTN: NP_001008212.

Constructs {#s4-2}
----------
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Table of constructs.

**DOI:** [http://dx.doi.org/10.7554/eLife.18544.023](10.7554/eLife.18544.023)

  **Identification number**   **Vector**     **Expression system**     **Expressing**                                      **Published**
  --------------------------- -------------- ------------------------- --------------------------------------------------- ---------------
  SMC3                        pGEX-4T-3      *E. coli* Rosetta pLysS   GST-Atg3                                            ([@bib54])
  SMC7                        pGEX-4T-3      *E. coli* Rosetta pLysS   GST-Atg5                                            this study
  SMC17                       pOPTH          *E. coli* Rosetta pLysS   6xHis-Atg7                                          ([@bib54])
  SMC34                       pOPTG          *E. coli* Rosetta pLysS   GST-Atg16                                           ([@bib54])
  SMC58                       pET-Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg8∆R117                                     this study
  SMC126                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg5, Atg12                                   ([@bib54])
  SMC131                      pCOLA Duet-1   *E. coli* Rosetta pLysS   Atg7, Atg10                                         ([@bib54])
  SMC156                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-mCherry-Atg19                                 ([@bib56])
  SMC159                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19                                           ([@bib56])
  SMC178                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg16-meGFP                                   ([@bib54])
  SMC179                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-meGFP-Atg8∆R117                               ([@bib54])
  SMC180                      pCOLA-Duet     *E. coli* Rosetta pLysS   6xHis-Atg16 (1--46)                                 ([@bib54])
  SMC185                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg34                                           ([@bib56])
  SMC188                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19W412A                                      ([@bib56])
  SMC293                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19(124--415)                                 ([@bib56])
  SMC294                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19(254--415)                                 ([@bib56])
  SMC295                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19(365--415)                                 ([@bib56])
  SMC300                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-prApe1(1--45)                                   ([@bib56])
  SMC301                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19(1--407)                                   ([@bib56])
  SMC309                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19(365--407)                                 this study
  SMC564                      pGEX-4T-3      *E. coli* Rosetta pLysS   GST-Atg4                                            ([@bib68])
  SMC595                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-prApe1(1--41)                                   this study
  SMC665                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg5(K57E), Atg12                             this study
  SMC668                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg5(N84E), Atg12                             this study
  SMC743                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg5(K57E,N84E), Atg12                        this study
  SMC772                      pGEX-4T-2      *E. coli* Rosetta pLysS   GST-Atg19(408--415)                                 this study
  SMC782                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg5-mCherry                                  this study
  SMC808                      pGEX-4T-1      *E. coli* Rosetta pLysS   GST-Atg19(365--407) F376A, F379A, L384A, L387A      this study
  SMC819                      pET Duet-1     *E. coli* Rosetta pLysS   6xHis-Atg16-mCherry                                 ([@bib54])
  SMC255                      pEGFP-C1       HeLa cell line            EGFP-ATG5                                           this study
  SMC398                      pmCherry-C1    Hela cell line            pmCherry-OPTN                                       this study
  SMC516                      pmCherry-C1    HeLa cell line            mCherry-p62                                         ([@bib65])
  SMC539                      pmCherry-C1    Hela cell line            pmCherry-NDP52                                      this study
                              pRS313         S. cerevisiae                                                                 ([@bib58])
                              pRS315,        S. cerevisiae                                                                 ([@bib58])
                              pRS316         S. cerevisiae                                                                 ([@bib58])
                              pRS415         S. cerevisiae                                                                 ([@bib58])
  pAB15                                      S. cerevisiae             9xmycHKMT-ATG19_cyc1term, pRS415, ATG19 Promoter    this study
  pCK48 (SMC199)              pRS315         S. cerevisiae             GFP-Atg8                                            ([@bib30])
  pLW38.1                                    S. cerevisiae             ATG13-HKMT, YCp111, ATG13 promoter                  ([@bib7])
  pLW52                                      S. cerevisiae             ATG2-9xmyc-HKMT, pRS415, ATG2 promoter              ([@bib7])
  pTP9 (SMC852)               pRS313         S. cerevisiae             endogenous promoter-6xmyc-Atg19                     this study
  SMC236                      pRS315         S. cerevisiae             endogenous promotor-Atg16 wild type - terminator    this study
  SMC270                      pRS316         S. cerevisiae             endogenous promoter-Atg5wild type-9xmyc             ([@bib54])
  SMC343                      pRS316         S. cerevisiae             6xmyc-Atg19 wild type                               ([@bib56])
  SMC381                      pRS316         S. cerevisiae             6xmyc-Atg19W412A                                    ([@bib56])
  SMC418                      pRS316         S. cerevisiae             6xmyc-Atg19 F376A, F379A,W412A                      ([@bib56])
  SMC422                      pRS316         S. cerevisiae             6xmyc-Atg19 F376A, F379A,P385A,E386A, W412A         ([@bib56])
  SMC524                      pRS315         S. cerevisiae             6xmyc-Atg19 wild type                               this study
  SMC678                      pRS315         S. cerevisiae             6xmyc-Atg19W412A                                    this study
  SMC690                      pRS316         S. cerevisiae             endogenous promoter-Atg5K57E-9xmyc                  this study
  SMC691                      pRS316         S. cerevisiae             endogenous promoter-Atg5N84E-9xmyc                  this study
  SMC692                      pRS316         S. cerevisiae             endogenous promoter-Atg5K57E,N84E-9xmyc             this study
  SMC836                      pRS315         S. cerevisiae             endogenous promotor-Atg16(D101A)-terminator         this study
  SMC837                      pRS315         S. cerevisiae             endogenous promotor-Atg16(E102A)-terminator         this study
  SMC838                      pRS315         S. cerevisiae             endogenous promotor-Atg16(D101A,E102A)-terminator   this study

Protein expression and purification {#s4-3}
-----------------------------------

A list of constructs for protein expression can be found in ([Table 1.](#tbl1){ref-type="table"}). Expression and purification of Atg19 and shortened variants thereof, Atg34 and prApe1(1--45) was described previously ([@bib56]). prApe1(1--41) was subcloned into pGEX4T-1 vector, expressed and purified as a GST fusion protein with the same approach as the propeptide prApe1(1--45) variant described in ([@bib56]). The mCherry-Atg19 was purified via a hexahistidine tag as described in ([@bib56]).

Atg12\~Atg5-Atg16, Atg12\~Atg5, Atg16 and Atg16-meGFP as well as all proteins required for Atg8\~PE conjugation (Atg3, Atg7, Atg10, Atg8∆R117, meGFP-Atg8∆R117) were expressed and purified as described previously ([@bib54]).

Atg5-Atg16 (1--46) for analytical size exclusion chromatography was produced by co-expressing Atg5 subcloned into pGEX4T-3 and the first 46 amino acids of Atg16 (Atg16 (1--46)) subcloned into pCOLADuet-1 in *E. coli* Rosetta pLySS. The co-transformed cells were grown at 37°C to an OD600 of 0.6, induced with 0.1 mM IPTG and further grown over night at 18°C. Cells were pelleted and resuspended in a buffer containing 50 mM HEPES pH 7.5, 300 mM NaCl, 1 mM MgCl~2~, 2 mM β−mercaptoethanol, complete protease inhibitors (Roche, Basel, Switzerland) and DNAse I (Sigma, USA, Missouri). Cells were disrupted by freeze-thawing and lysates were cleared by ultracentrifugation (140,000 *g* for 30 min at 4°C in a Ti45 rotor Beckman, Brea, CA, USA). Supernatants were applied to glutathione beads (GE Healthcare, Buckinghamshire, UK) for 1 hr at 4°C. Beads were washed five times with 50 mM HEPES, 300 mM NaCl, 1 mM DTT and the protein was cleaved from the GST tag by incubation with thrombin protease (SERVA, Heidelberg, Germany) overnight at 4°C. The supernatant containing Atg5 - Atg16 (1--46) was concentrated and applied to a Superdex 200 (16/60 prep grade, GE Healthcare) and eluted with a buffer containing 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT. Fractions containing pure protein were pooled, concentrated, frozen in liquid nitrogen and stored at −80°C.

For all other experiments, wild type Atg5 as well as Atg5(K57E), Atg5(N84E), Atg5(K137), Atg5(R208) and Atg5(K57E,N84E) were tagged with an N-terminal hexahistidine-tag followed by a TEV cleavage site. The proteins were co-expressed and purified in complex with Atg16 (1--46) as described in ([@bib54]).

Atg16-mCherry with an N-terminal hexahistidine-tag followed by a TEV cleavage site (pETDuet-1) was expressed in *E. coli* Rosetta pLysS. Cells were grown at 37°C to an OD600 of 0.6 and induced with 0.1 mM IPTG. The protein expression continued overnight at 16°C. Cells were pelleted and resuspended in a buffer containing 50 mM HEPES pH 7.5, 300 mM NaCl, 10 mM Imidazole, 1 mM MgCl~2~, 2.5 mM β−mercaptoethanol, complete protease inhibitors (Roche) and DNAse I (Sigma). Cells were lysed by freeze-thawing followed by 30 s sonication and the lysate was centrifuged at 40000 rpm (Beckman Ti45 rotor) for 40 min at 4°C. The supernatant was applied to a 5 ml Ni-NTA column (GE Healthcare) and eluted via a stepwise imidazole gradient (50, 75, 100, 150, 200, and 300 mM). Protein-containing fractions were pooled and subjected to overnight cleavage with TEV protease at 4°C in the dark. The cleaved protein was applied to a Superdex 200 column (16/60 prep grade, GE Healthcare, Sweden) and eluted with a buffer containing 25 mM HEPES pH 7.5, 500 mM NaCl and 1 mM dithiothreitol (DTT). Fractions containing the purified proteins were pooled, concentrated, frozen in liquid nitrogen, and stored at −80°C.

For purification of Atg5-Atg16 and Atg5-Atg16-meGFP, Atg5 was expressed as a GST-tagged protein in *E. coli* Rosetta pLysS from pGEX4T-3 vector. The expression and purification followed the same procedure as for Atg5-Atg16 (1--46). In short, cells were grown at 37°C to an OD600 of 0.5 and induced with 100 μM IPTG for 16 hr at 18°C. Cells were disrupted by freeze-thawing and the cleared lysate was incubated with glutathione beads (Glutathione Sepharose 4B, GE Healthcare, Uppsala, Sweden). The protein was cleaved off from the beads with thrombin protease (SERVA). Next, the supernatant containing Atg5 was mixed with purified Atg16 or Atg16-meGFP in a molar ratio 1:1 at 4°C for 30 min, concentrated and the resulting Atg5-Atg16 or Atg5-Atg16-meGFP complex was further purified by size exclusion chromatography on Superdex S200 (16/60 prep grade, GE Healthcare).

The wild type and Atg12\~Atg5-Atg16 (untagged and -mCherry tagged) as well as the point mutants Atg12\~Atg5 (K57E)-Atg16-mCherry, Atg12\~Atg5 (N84E)-Atg16-mCherry, Atg12\~Atg5 (K57E,N84E)-Atg16-mCherry were purified in two steps. In the first step, Atg12\~Atg5 wild type conjugate or point mutants thereof were generated as described in ([@bib54]). Next the conjugates were mixed with purified Atg16 or Atg16-mCherry in a molar ratio 1:1 ratio and incubated on ice for 30 min. The resulting Atg12\~Atg5-Atg16 or Atg12\~Atg5-Atg16-mCherry complexes were further purified by size exclusion chromatography on Superdex S200 (16/60 prep grade, GE Healthcare).

The Atg5-mCherry was subcloned into pETDuet-1 vector with N-terminal hexahistidine-tag followed by a TEV cleavage site (6xHis-TEV-Atg5-mCherry). The protein was co-expressed as a complex with the first 46 amino acids of Atg16 (Atg16 (1--46)) subcloned into pCOLADuet-1. The *E. coli* Rosetta pLysS cells were co-transformed with 6xHis-TEV-Atg5-mCherry and Atg16(1--46) and grown at 37°C to an OD600 of 0.6, induced with 1 mM IPTG and further grown overnight at 18°C. Cells were pelleted and resuspended in a buffer containing 50 mM HEPES pH 7.5, 300 mM NaCl, 10 mM Imidazole, 1 mM MgCl~2~, 2 mM β−mercaptoethanol, complete protease inhibitors (Roche) and DNAse I (Sigma). Cells were disrupted by freeze-thawing followed by 30 s sonication. Lysates were cleared by ultracentrifugation (140,000 *g* for 30 min at 4°C in a Beckman Ti45 rotor). Supernatant was applied to a 5 ml Ni-NTA column (GE Healthcare, Sweden) and eluted via a stepwise imidazole gradient (50, 75, 100, 150, 200, and 300 mM). Protein-containing fractions were pooled, concentrated, applied onto a Superdex 200 column (16/60 prep grade, GE Healthcare) and eluted with a buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl and 1 mM dithiothreitol (DTT). Fractions containing the purified proteins were pooled, concentrated, frozen in liquid nitrogen, and stored at −80°C.

Atg4 was expressed and purified as described in ([@bib68]).

Analytical SEC {#s4-4}
--------------

To probe the direct Atg19 interaction with Atg5-Atg16 (1--46) in solution the analytical size exclusion chromatography was performed. Atg19 and Atg5-Atg16 (1--46) were premixed at 55 μM, concentrated to 580 μM (Amicon Ultra-0.5 ml Centrifugal Filters 3 kDa MWCO, Millipore, Cork, Ireland) and subsequently applied onto a Superose 6 gel filtration column (PC 3.2/30, GE Healthcare) equilibrated with a buffer containing 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT. Resulting fractions were subjected to SDS-PAGE and the protein bands were detected with Coomassie Brilliant Blue staining.

GST pull down binding assays {#s4-5}
----------------------------

To perform GST pull down binding assays GST or GST-fused Atg19 wild type or shortened variants thereof were used as a bait and Atg12\~Atg5-Atg16 or Atg12\~Atg5-Atg16-meGFP, Atg12\~Atg5, Atg5-Atg16 (1--46), Atg5-Atg16 or Atg16-meGFP were used as a prey. The purified GST-fused proteins (5 µM for pull downs in [Figures 1A,C](#fig1){ref-type="fig"}, [2A and C](#fig2){ref-type="fig"}; 20 µM for pull downs in [Figure 2E](#fig2){ref-type="fig"}, [Figure 3---figure supplements 1](#fig3s1){ref-type="fig"} [Figure 4C,](#fig4){ref-type="fig"}) and purified GST-free proteins (5 µM) as well as glutathione Sepharose 4B beads (GE Healthcare) were simultaneously incubated for 1 hr at 4°C on a rotating wheel. After washing the beads three times with 25 mM HEPES at pH 7.5, 150 mM NaCl, 1 mM DTT (and 0.1% TritonX100 for pull-downs in [Figures 1A, C](#fig1){ref-type="fig"}, [2A and C](#fig2){ref-type="fig"}), the glutathione beads together with bound proteins were subjected to SDS-PAGE. The protein bands were detected either by Coomassie Brilliant Blue staining or Ponceau or by immunoblotting carried out with a mouse monoclonal anti-Atg5 ([@bib54]), mouse anti-GFP (Roche, diluted 1:5000 in 0.5% Milk in TBST, 1% TritonX100) or anti-GST (diluted 1:1000 in 3% Milk in TBST, 1% TritonX100) antiserum used as primary antibodies. Secondary antibodies were used as described in ´*prApe1 processing assay*´.

Competition assay {#s4-6}
-----------------

For experiments shown in [Figure 3E](#fig3){ref-type="fig"}, glutathione Sepharose 4B beads were incubated with a 30 µM GST or GST-Atg19 (365--415) solution for 30 min at 4°C on a rotating wheel and afterwards twice washed in buffer containing 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT. 2 µl of these beads were added to a Atg5-mCherry-Atg16 (1--46) solution pre-pipetted in the wells of a 384-wells glass-bottom plate (Greiner Bio One, Frickenhausen, Germany) resulting in a final concentration of 18 µM. After at least 20 min of incubation, samples were imaged as described in the 'Microscopy-based protein-protein interaction assay' section. For the competition experiment GFP-Atg8∆R117 (or buffer) was added to the wells at a final concentration of 18 µM (1x initial Atg5-mCherry-Atg16 (1--46) concentration) and allowed to compete the Atg5-mCherry-Atg16 (1--46) protein and to bind to the GST-protein for at least 20 min. An equivalent volume of empty buffer was added to the control well in order to account for the dilution factor applied to the sample. After imaging, Atg8 (or buffer) was further added to the same wells at a final concentration of 400 µM (22x initial Atg5-mCherry-Atg16 (1--46) concentration) and allowed to reach the equilibrium of binding for at least 20 min. The samples were then imaged as described in Microscopy-based protein-protein interaction assay´ section.

For experiments shown in [Figure 3G](#fig3){ref-type="fig"}, glutathione Sepharose 4B beads were incubated with a 10 µM GST or GST-prApe1(1--40) solution for 30 min at 4°C on a rotating wheel and subsequently washed twice in buffer containing 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT. The beads were further incubated with a solution of Atg19 at 20 µM for at least 30 min. Beads were washed twice and pipetted directly to a 96-well-plate glass bottom well pre-filled with a solution of Atg12\~Atg5-Atg16-mCherry at a final concentration of 5 µM. After imaging, GFP-Atg8 solution was added to the well at a final concentration of 5 µM (ratio 1:1 with initial concentration of Atg12\~Atg5-Atg16-mCherry). The reaction was allowed to reach the equilibrium for 20 min and imaged as described above. GFP-Atg8 solution was added to the well at a final concentration of 50 µM (ratio 1:10 with initial concentration of Atg12\~Atg5-Atg16-mCherry). The proteins were allowed to reach the equilibrium of binding and imaged immediately.

Preparation of small unilamellar vesicles (SUVs) {#s4-7}
------------------------------------------------

SUVs employed in the Atg8 conjugation assay were composed of 39% POPC (Avanti Polar Lipids (Alabaster, AL, USA), Inc., 850457C, 10 mg/ml), 35% POPS (Avanti Polar Lipids, Inc., 840034C, 10 mg/ml), 21% POPE (Avanti Polar Lipids, Inc., 850757C, 10 mg/ml), 5% PI3P (Avanti Polar Lipids, Inc., 850150P, 1 mg/ml). PI3P stock was prepared by resuspension in CHCl~3~ and subsequent drying under an argon stream and further drying for 1 hr in a dessicator. PI3P was then resuspended in CHCl~3~:MeOH:1M HCl (molar ratio 2:1:0.1) and incubated for 15' for protonation. The lipid was again dried under an argon stream and subsequently for one hour in a dessicator, and then resuspended in CHCl~3~:MeOH (3:1) and dried again under an argon stream. After one wash with CHCl~3~, PI3P was resuspended in CHCl~3~ to a final concentration of 1 mg/ml. Corresponding amounts of the lipid stocks were transferred into a glass vial and mixed well before they were dried under an argon stream. The dried lipids were further dried for an additional hour in a desiccator. Subsequently, the dried lipids were rehydrated with liposome buffer (25 mM HEPES pH 7.5, 137 mM NaCl, 2.7 mM KCl and 1 mM DTT) for 15 min. The lipids were resuspended by tapping and gently sonicated for 2 min in a water bath sonicator. The resuspended SUVs were then extruded 21 times through 0.4 μm membrane followed by extrusion through a 0.1 μm membrane (Whatman, Nucleopore, UK) using the Mini Extruder from Avanti Polar Lipids Inc.. The final SUVs suspension has a concentration of 1 mg lipids/ml buffer. SUVs are stable for 2--3 days when stored at 4°C.

Lipid mixture used for the in vitro reconstitution of Atg8 lipidation on cargo-mimetic beads and for experiment in [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, was composed of 39--35% DOPC, 35% DOPS, 20% DOPE, 5% PI~3~P, 1--5% of ATTO390-DOPE and buffer was composed of 25 mM HEPES pH 7.5, 150 NaCl and 1 mM DTT.

Lipid composition of SUVs used in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} consists of 39% POPC, 35% POPS, 20% POPE, 5% PI~3~P, 1% of Rhodamine-DOPE and buffer was composed of 25 mM HEPES pH 7.5, 150 NaCl and 1 mM DTT.

Atg8 conjugation assay using SUVs {#s4-8}
---------------------------------

The conjugation reactions were performed at 30°C and all buffers, solutions and the SUVs with the exception of the proteins were pre-warmed to this temperature. Atg3 and Atg7 were used at final concentrations of 1 µM, whereas Atg8∆R117 was used at a final concentration of 5 µM and Atg12\~Atg5 wild type and mutants were used at 0.2 µM. ATP was used at a final concentration of 100 µM, while MgCl~2~ was used at a final concentration of 1 mM. The reactions were stopped by the addition of loading dye (12% SDS, 6% beta-mercaptoethanol, 30% Glycerol, 0.05% Coomassie Brilliant blue G-250, 150 mM Tris-HCl pH 7).

The reactions were run on 11% SDS/polyacrylamide gels containing 4.5 M urea in the separating parts. The gels were then stained with Coomassie staining solution (40% methanol, 10% acetic acid, 0.2% Coomassie Brilliant Blue).

For [Figure 5E](#fig5){ref-type="fig"}, the gels of three independent experiments were quantified using the Analyze Gel tool of ImageJ. Statistical analysis was done in Prism by multiple t tests (unpaired, two-tailed, Holm-Sidak method). A p-value \< 0.05 was considered to be significant.

Liposome co-sedimentation assay {#s4-9}
-------------------------------

Small unilamellar vesicles (SUVs) were composed of 35% DOPC, 35% DOPS, 20% DOPE, 5% PI~3~P, 5% of ATTO390-DOPE (Avanti Polar Lipids, Inc.) and prepared as described above. After the drying step the lipids were resuspended in 150 mM NaCl, 50 mM HEPES pH 7.5, 1 mM DTT buffer. For the Atg12\~Atg5-Atg16-mCherry and point mutants thereof binding to lipids, 25 µl of freshly prepared SUVs were mixed with 5 µg of protein at the final reaction volume of 50 µl in 150 mM NaCl, 50 mM HEPES pH 7.5, 1 mM DTT buffer. The reaction was incubated for 30 min at room temperature. Next, the liposome bound protein was pelleted by ultracentrifugation for 10 min at 100,000xg at 22°C. Supernatants and pellets were separated and equal amounts were applied on 12% SDS/polyacrylamide gel and visualized by Coomassie Brilliant Blue staining (40% ethanol, 10% acetic acid, 0.2% Coomassie Brilliant Blue).

In vitro reconstitution of Atg8 lipidation on cargo-mimetic beads {#s4-10}
-----------------------------------------------------------------

For [Figure 6A,B](#fig6){ref-type="fig"}: Glutathione Sepharose 4B beads were coated with GST-prApe1(1--45) at a final concentration of 25 µM, incubated for 30 min at 4°C and washed twice with buffer containing 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT. Beads were further incubated with Atg19 at a final concentration of 15 µM, washed two times and further incubated with Atg12\~Atg5-Atg16-mCherry at a final concentration of 12.5 µM. After 2x washings, 2 µl of the beads were pipetted into the well of a 384-wells plate, pre-filled with 22 µl buffer and subsequently 1 µl ATTO390-containing SUVs was added to the reaction. Conjugation reaction in [Figure 6A,B](#fig6){ref-type="fig"} was conducted in the presence of 0.5 mM MgCl~2~, 0.3 µM Atg7, 0.3 µM Atg3 and 0.1 µM meGFP-Atg8∆R117 with/without 1 mM ATP over night at 4°C with gentle mixing on an orbital shaker.

For the experiments shown in [Figure 6C](#fig6){ref-type="fig"} and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, beads were prepared as for [Figure 6A](#fig6){ref-type="fig"} regarding the GST-protein, Atg19 and Atg12\~Atg5-Atg16-mCherry. Beads were incubated overnight at 4°C under gentle rolling with an excess of ATTO390-SUVs membranes. The day after beads were washed twice using 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT buffer (beads pelleted by sedimentation for 10 min on ice) and overnight conjugation reaction was set up as described for [Figure 6A,B](#fig6){ref-type="fig"}. Imaging was performed using a Zeiss Confocal LSM700 microscope equipped with a 20x/0.8 Plan-Apocromat Objective. The FRAP experiments shown in [Figure 6B and D](#fig6){ref-type="fig"} were conducted under following conditions: 10 ms FRAP time/pixel; laser beam diameter 10 pixels. Acquisition was performed either every 5 or 10 s.

For the de-conjugation reaction Atg4 was added to the well containing beads, prepared as in [Figure 6A](#fig6){ref-type="fig"}, at a final concentration of 0.3 µM together with EDTA at a final concentration of 1 mM. Beads were imaged with a Spinning Disk microscope at the indicated time points of reaction.

Microscopy-based protein-protein interaction assay {#s4-11}
--------------------------------------------------

For the experiments shown in [Figures 1B](#fig1){ref-type="fig"}, [2F--G](#fig2){ref-type="fig"} 20 µl glutathione Sepharose 4B beads slurry (GE Healthcare) were mixed with GST-fused bait proteins (GST-Atg19 or GST-Atg19 variants) to the final concentration of 20 µM and incubated on a rotating wheel at 4°C for at least 30 min. Subsequently the beads were washed twice with 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT. In these experiments the prey Atg12\~Atg5-Atg16-mCherry was added at the final concentration of 5 µM. After 30 min of incubation at 4°C a 5 µl aliquot of beads was transferred into the well of a 96-well glass-bottom microplate (Greiner Bio-One) pre-filled with 35 µl of 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT and immediately imaged with a Spinning Disk microscope.

For the experiments shown in [Figure 3B](#fig3){ref-type="fig"}, GST-fused proteins were incubated with Sepharose beads at a final concentration of 30 µM and Atg5-mCherry-Atg16 (1--46) was used at a final concentration of 18 µM.

For the experiments shown in [Figure 5B](#fig5){ref-type="fig"}, Sepharose beads were incubated with GST-proteins at 25 µM, washed twice with 25 mM HEPES at pH 7.5, 150 mM NaCl and 1 mM DTT buffer and further incubated with Atg19 at 15 µM. After two washings, the beads were incubated with Atg12\~Atg5-Atg16-mCherry (wild type and mutants) at a final concentration of 8.8 µM.

For the experiments shown in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, GST-prApe1(1--45) was incubated with Sepharose beads at 5 µM concentration. Beads were washed twice and further incubated with Atg19 wild type and mutant at a final concentration of 5 µM. Beads were washed twice and further incubated with Atg12\~Atg5-Atg16-meGFP at a final concentration of 5 µM.

The pictures shown in [Figure 1B](#fig1){ref-type="fig"}, [Figure 2F,G](#fig2){ref-type="fig"}, [Figure 3B,E](#fig3){ref-type="fig"}, [Figures 5B](#fig5){ref-type="fig"} and [6B,D](#fig6){ref-type="fig"} and those acquired for quantifications (including [Figure 3G ](#fig3){ref-type="fig"}) were obtained using a LD Achroplan 20x/0.4 Corr Obje[Figure 3](#fig3){ref-type="fig"}ctive mounted on a confocal spinning disc microscope (Visitron) installed with VisiView 2.1.1 software and processed with ImageJ. To quantify the protein and membrane recruitment to beads the maximum brightness along a straight line drawn through a single bead was taken (maximal fluorescence). Next, the average brightness of an empty portion of each picture was measured (background fluorescence) and subtracted from the maximal fluorescence for each bead. All intensities were normalized to the signal of the wild type protein.

M-Track assay {#s4-12}
-------------

The M-Track methylation assay was conducted as previously described ([@bib69]) ([@bib50]).

Atg5 - Atg19 co-immunoprecipitation {#s4-13}
-----------------------------------

For blots shown in [Figures 1D](#fig1){ref-type="fig"} and [3D](#fig3){ref-type="fig"}, yeast strain BY4741-*atg8*∆*atg19*∆ with integrated Atg5-TAP was transformed with empty vector pRS315 or vector containing 6xmyc-Atg19 wild type or mutants. Pre-cultures of yeast were grown in selective medium to log phase and then used to inoculate YPD cultures for an overnight growth in log phase. Cells were harvested by centrifugation for 15 min at 3000xg and then washed once with PBS with 2% glucose and 0.5% ammoniumsulfate. Subsequently, the cells were resuspended in a volume of IP-Buffer corresponding to the volume of the pellet (20 mM PIPES pH 6.8, 50 mM KCl, 100 mM K Acetate, 10 mM MgSO~4~, 10 µM ZnSO~4~, 1 mM PMSF, 1 mM NaF, 1 mM Na~3~VO~4~, 20 mM beta-GP, 0.5 mM DTT, complete PI tablet (Roche)(two tablets/100 ml solution), 0.1% Triton X100, and frozen in droplets in liquid nitrogen. The cells were then disrupted with a freezer mill (6770; SPEX), the extract was thawed in lysis buffer and cleared by centrifugation. The cleared extract was incubated with 30 µL of magnetic beads (Dynabeads M-270 Epoxy, Invitrogen, Norway) coupled to rabbit IgG from serum (I5006-10MG, Sigma) for 1 hr at 4°C with rotation. The beads were washed five times for 10 min in lysis buffer with rotation and then incubated for 10 min at 95°C with urea loading buffer (116 mM Tris pH 6.8, 4.9% Glycerol, 8 M Urea, 8% SDS).

Proteins were separated by SDS-PAGE and subjected to Western blotting. For detection, rabbit anti-TAP (ThermoScientific, \#CAB1001, 1:1 000 for lysates or unbound fractions and 1:10 000 for Co-IP samples respectively in 3% milk/TBST), mouse anti-Myc antibody (clone 4A6, 1:500 in 3% milk/TBST) and mouse-anti Pgk1 (Invitrogen, \#459250, California, USA; 1:20 000 in 3% milk/TBST) were used to incubate the Western blots at 4°C overnight. Goat anti-mouse IgG HRP (Dianova, \#115--035, Germany; 1:10 000 in 3% milk/TBST) and goat anti-rabbit IgG-HRP (Dianova, \#111-035-003, Germany; 1:10 000 in 3% milk/TBST) were used to incubate the membranes for 1 hr at room temperature. All the washing steps were conducted using TBS-Tween 0.1%.

The gels were quantified using the Analyze Gel tool of ImageJ. Values were normalized to the wild type, three independent experiments were quantified. Statistical analysis was done in Prism by Welch's t test. A p-value \< 0.05 was considered to be significant.

For blots shown in [Figure 5F](#fig5){ref-type="fig"}, yeast strain BY4741-*atg16*∆a*tg19*∆ with integrated Atg5-TAP or Atg5 K57E,N84E-TAP was transformed with a vector containing either Atg16 wild type or Atg16 E102A. In addition, they were also transformed with empty vector pRS313 or vector containing 6xmyc-Atg19 wild type. Pre-cultures of yeast were grown in selective medium in log phase and then used to inoculate YPD cultures for a 6 hr growth in log phase. Cells were harvested by filtration on a 90 mm glass filter with pore size 0.45 µm (SterliTech) followed by freezing in liquid nitrogen. Subsequently, a volume of IP-Buffer corresponding to the volume of the pellet was frozen in droplets in liquid nitrogen and added. The cells were then disrupted with a freezer mill (6770; SPEX), and co-immunoprecipitation was performed as described for the Atg5 - Atg19 co-immunoprecipitation with Atg19 mutants above.

prApe1 processing assay {#s4-14}
-----------------------

A list of constructs for the yeast experiments can be found in ([Table 1.](#tbl1){ref-type="table"}). ([Table 2.](#tbl2){ref-type="table"}) lists the yeast strains used in this study. For the prApe1 processing assay of Atg5 mutants, yeast strains BY4741 wild type and BY4741-*atg5△* were transformed with empty vector pRS316 or vector containing wild type or mutant Atg5-6xmyc. For the prApe1 processing assay of Atg5 mutants in combination with Atg16 mutants Atg5-TAP and Atg5 K57E,N85E-TAP were integrated stably into the genome of *atg5∆atg16∆* strains and transformed with empty vector pRS315 or vector containing wild type or mutant forms of Atg16 wild type or mutants.

Pre-cultures of yeast were grown in selective medium to log phase and then used to inoculate complete medium for an overnight growth in log phase. The Atg5 with the Atg16 mutants were additionally subjected to nitrogen-starvation for 6 hr as described in 'GFP-Atg8 cleavage assay*'*. Whole cell lysates were prepared by trichloroacetic acid extractions. Proteins were separated by SDS-PAGE and subjected to Western blotting. For detection, rabbit-anti Ape1 antiserum ([@bib54]); 1:20000 in 3% milk/TBST), mouse anti-Myc antibody (clone 4A6, 1:1000 in 3%milk/TBST) and mouse-anti Pgk1 (Invitrogen, \#459250; 1:20000 in 3%m/TBST) were used to incubate the Western blots at 4°C overnight or at room temperature for 1 hr. Goat anti-mouse IgG HRP (Dianova, \#115--035; 1:10000 in 3%m/TBST) and goat anti-rabbit IgG-HRP (Dianova, \#111-035-003; 1:10000 in 3%milk in TBST) were used for a subsequent incubation of 30 min at room temperature. All the washing steps were conducted using TBS-Tween 0.1%. Quantification of prApe1 processing was performed using Analyze Gel tool in ImageJ software. Band intensities of pr- and mature Ape1 were measured and the ratio of mature Ape1 to prApe1 was calculated. Values calculated for wild type samples were set to 100%. At least three independent replicates were considered for each set of mutants tested.

GFP-Atg8 cleavage assay {#s4-15}
-----------------------

Yeast wild type and atg5∆ BY4741 strains ([Table 2.](#tbl2){ref-type="table"}) were co-transformed with empty vector (pRS316) or wild type or mutant K57E,N84E Atg5, together with the GFP-Atg8 expressing plasmid (SMC199). Cells were grown to log-phase in selective medium (Formedium, UK) and further grown for an overnight in log phase in the same selective medium. After two washes in SD-N, cells were transferred to SD-N (Formedium, UK) and subjected to nitrogen starvation for 5 hr. Lysates were prepared as described in ´*prApe1 processing assay´* and samples were analysed by Western blotting. Mouse anti-GFP antibody (1:2000 dil. in 3.5% milk/PBST, Roche, Germany) was used for detection of GFP-Atg8. Mouse anti-Myc, anti-Pgk1 antibodies and anti-mouse secondary antibody were used as described in ´prApe1 processing assay*´.*

Pho8∆60 assay {#s4-16}
-------------

Yeast strains SMy33 and SMy62 ([Table 2.](#tbl2){ref-type="table"}) were transformed with empty vector pRS316 or pRS316 containing wild type or the mutant Atg5-6xmyc. Pre-cultures were grown to log-phase in selective medium and subsequently transferred to complete medium for an overnight-log-culture. 20 OD-units were taken as Log-aliquots, washed with 0.85% NaCl, 1 mM PMSF and frozen in lysis-buffer (20 mM PIPES pH6.8, 0.5% TritonX100, 50 mM KCl, 100 mM KAcetate, 10 mM MgSO~4~, 10 μM ZnSO~4~, 1 mM PMSF, protease inhibitor mix tablet, Roche). The cultures were exposed to nitrogen-starvation for 5 hr and aliquots were washed and frozen as described above. The total proteins were extracted by bead-beating. The concentration of the lysate was determined by Bradford. All lysates were adjusted with lysis buffer to a final concentration of 500 µg/ml.

The enzymatic assay was performed using 4-nitrophenol phosphate powder (Sigma, 71768--5G) diluted to final concentration of 1.25 mM in reaction buffer (0.4% TritonX100, 10 mM MgSO~4~, 10 µM ZnSO~4~, 250 mM TrisHCl, pH 8.5) as a substrate. The formation of the product 4-nitrophenol was measured using a spectrophotometer plate-reader at 405 nm. An enzyme blank (composed of lysate and reaction buffer without substrate) was measured and subtracted for every sample. The molarity of the reaction product was determined with a standard curve using 4-nitrophenol 10 mM solution (Sigma, N7660-100ML). An enzyme blank (containing substrate in reaction buffer and lysis buffer without enzyme) was subtracted to the standard curve. The reaction was stopped at a determined time point (same for every sample) between 5 and 25 min with 1M glycine, pH 11 adjusted with 5 M KOH. The activity-units (AU) were calculated using the following formula:$$activity~\left\lbrack {AU} \right\rbrack = \frac{c~\left( pNP \right)~\left\lbrack nM \right\rbrack}{t\left\lbrack {min} \right\rbrack*~protein~~\left\lbrack mg \right\rbrack}$$

Cell culture {#s4-17}
------------

HeLa cells (CCL-2) were directly purchased from ATCC (Manassas, Virginia, USA) and their identity was not authenticated after purchase. Cells were routinely tested for mycoplasma contamination by PCR (GATC, Konstanz, Germany) and tested negative. Cells were cultured in Dulbecco's modified Eagle medium (DMEM) high glucose, GlutaMAX, pyruvate (Gibco, Waltham, MA, USA) supplemented with 10% heat inactivated fetal bovine serum (FBS, Sigma, MO, USA), 100 units/mL penicillin and 100 μg/mL streptomycin (Gibco) at 37°C and 5% CO~2~. Cells were used from passage 5 to 20.

Transient transfection of siRNA and plasmids {#s4-18}
--------------------------------------------

A list of constructs for transfections can be found in ([Table 1.](#tbl1){ref-type="table"}). HeLa cells were seeded to 6-well plates on day 1. Transfection with siRNA against SQSTM1/p62 (sip62) or non-targeting siRNA (siControl) was performed on day 2, transfection with plasmids containing siRNA resistant mCherry-p62 and GFP-ATG5 or GFP was performed on day 4. Cells were lysed on day 5.

For one reaction 50 pmol of sip62 (J-010230--05, Dharmacon, Buckinghamshire, UK) or siControl (D-001810--10, Dharmacon) were pre-incubated with 2.5 µl of Lipofectamine RNAimax (Invitrogen, Waltham, MA, USA) in 500 µl serum-free medium at RT for 20 min. The formed complex was added to cells supplied with 2 ml fresh DMEM containing serum and antibiotics and incubated for two days. Thereafter co-transfection of plasmids containing a siRNA resistant p62 variant in pmCherry-C1 (SMC516, [@bib65]) and Atg5 in pEGFP-C1 (SMC255) or pEGFP-C1 vector only was performed. 1 to 1.5 µg of plasmid-DNA were mixed with Fugene6 (Promega, WI, USA) in a 1 μg:3 μl ratio (DNA:Fugene6) in serum-free medium and incubated at RT for 15 to 45 min. The mixture was added to cells supplied with 2 ml fresh DMEM containing serum and Pen/Strep and incubated for 24 hr.

For experiments shown in [Figure 1H](#fig1){ref-type="fig"} 2 × 10\^5 cells/well were seeded in 6-well plates on day 1, and transfected with FuGene6 (Promega) according to manufacturer's instructions on day 2. 0.5 µg of each pmCherry-based vector plus 0.5 µg of empty pEGFP-C1 or 1 µg of pEGFP-ATG5 were employed per well, two wells were transfected per condition. Cells were lysed as described below on day 3.

For lysis cells were washed with cold PBS, 100 µl lysis buffer (20 mM Tris pH 8.0, 10% glycerol, 135 mM NaCl, 0.5% NP-40, complete protease inhibitor (EDTA-free, Roche), 2.5 mM MgCl~2~, DNase) was added per well and lysis performed for 20 min at 4°C. Lysates from two wells were pooled, cell debris was removed by centrifugation at 16000 g for 10 min at 4°C and supernatant kept frozen at −80°C until use.

Lysates for the microscopy based assay needed to be more concentrated and were therefore prepared by trypsinization of cells followed by a PBS wash and lysis of cell pellets from two pooled wells with 100 µl lysis buffer containing 0.2% NP-40.

Pull down and microscopy based assay using GFP-TRAP beads {#s4-19}
---------------------------------------------------------

The protein concentration in all HeLa cell lysates was measured with Bradford's method and lysates were normalized to each other accordingly. For the pull-down shown in [Figure 1F](#fig1){ref-type="fig"}, GFP-Trap_A beads (ChromoTek) were mixed with empty Sepharose beads (Sigma) in a 1:4 ratio and equilibrated in wash buffer (20 mM Tris pH 8.0, 10% glycerol, 135 mM NaCl). Lysates were diluted with 1.5 volumes of wash buffer and incubated with 40 µl equilibrated bead slurry for 1 hr at 4°C with gentle agitation. Beads were washed three times with wash buffer, taken up in 40 µl Laemmli loading buffer, boiled 10 min at 95°C and bound proteins were separated by SDS-PAGE and analysed by Western blotting.

For visualizing protein interaction at equilibrium ([Figure 1G](#fig1){ref-type="fig"}) 50 µl lysate were incubated with 5 µl equilibrated GFP-Trap_A beads for 1 hr at 4°C. 15 µl of this bead dispersion were added to 20 µl of the corresponding residual lysate prepared in a 96-well plate and imaged using a spinning disc microscope (Visitron).

Quantification of microscopy GFP-TRAP experiments ([Figure 1G](#fig1){ref-type="fig"}) was performed using ImageJ Software. A z-projection using the maximum intensity values was generated from every stack. Intensity values of 30 pixels along the rim of each bead (oval selected in the GFP-channel but values measured in the mCherry-channel) were measured with Oval_Profile.java plugin, averaged and the background from a representative empty area in the image was subtracted.

For experiments shown in [Figures 1H](#fig1){ref-type="fig"} and 5 µL of GFP-TRAP beads (Chromotek, Germany) were mixed with 15 µL of empty sepharose 4B beads per each sample, and washed three times in IP wash buffer (20 mM Tris pH8, 135 mM NaCl, 10% glycerol). 15 µL of lysates were taken as input (approx. 7.5% of the total volume). The remaining lysate was added to the beads and incubated for 1 hr rotating at 4°C. Beads were washed three times with IP wash buffer and finally resuspended in 15 µL SDS loading dye. Input and bead samples were subjected to Western blot analysis. Membranes were ultimately developed with Clarity ECL substrate (BioRad) or with SuperSignal West Femto substrate (ThermoFisher Scientific, Rockford, IL, USA) if needed. The signal was recorded with a ChemiDOC Touch (Biorad) imager. For quantification of band intensities, only non-saturated exposures were considered, lanes were defined in ImageJ and the lane profile plotted. The area under the peak of relevant bands was taken as readout. The beads/input enrichment factor (EF) was calculated according to the following equation:$$\frac{BEADS_{GFP - ATG5}/BEADS_{GFP}}{INPUT_{GFP - ATG5}/INPUT_{GFP}}*\frac{GAPDH_{GFP - ATG5}}{GAPDH_{GFP}}$$

Where *BEADS* and *INPUT* indicate the cargo receptor's band intensity in the respective fraction, *GAPDH* indicates the band intensity of the anti-GAPDH blot, and *GFP-ATG5* and *GFP* indexes denote the sample. Interactions were considered reliable only for EF \> 2.

Antibodies {#s4-20}
----------

The following antibodies were used for detection of proteins in GFP-TRAP experiments on HeLa lysates are. Mouse anti-p62 (BD Bioscences, \#610832, Franklin Lakes, NJ, USA) was used at 1:1000 dilution; Rabbit anti-NDP52 (Cell Signaling, \#9036) was used at 1:1000 dilution; Rabbit anti-OPTN (Sigma, HPA003279) was used at 1:500 dilution; Mouse anti-GFP (Roche, cat. 11 814 460 001) was used at 1:1000 dilution; Mouse anti-GAPDH (Sigma, Clone GAPDH-71.1) was used at 1:25000 dilution. HRP-conjugated goat anti-Rabbit and anti-Mouse (Jackson

ImmunoResearch, \#111-035-003 and 115-035-003, respectively) were used at 1:10000 dilution.

Yeast strains {#s4-21}
-------------

10.7554/eLife.18544.024

###### 

Yeast manipulation and strain list.

**DOI:** [http://dx.doi.org/10.7554/eLife.18544.024](10.7554/eLife.18544.024)

  Name          Genotype                                                                     Background   Source
  ------------- ---------------------------------------------------------------------------- ------------ ------------
  BY4741/SMy1   Mat a; his3△1, leu2△0,met15△0, ura3△0                                        BY474x       Euroscarf
  BY4743        Diploid; his3△1/his3△1, leu2△0/leu2△0, met15△0/met15△0, ura3△0/ura3△0        BY474x       Euroscarf
  SMy2          Mat a; atg5::KanMX                                                           BY474x       Euroscarf
  SMy33         ∆pho8::pho8∆60His,∆pho13::kan                                                BY474x       ([@bib56])
  SMy62         ∆Atg5::nat; pho8∆60::His; ∆pho13::KanMX                                      BY474x       [@bib56])
  SMy147        Mat a; atg19::KanMX                                                          BY474x       Euroscarf
  SMy196        Mat a; ATG5-TAP:URA3, atg19::KanMX, atg8::NatMX                              BY474x       this study
  SMy201        Mat a; ATG16-TEV-2xProtA-4xH3-5xHA:URA3; atg19::KanMX                        BY474x       this study
  SMy239        Mat a; ape1::KanMX                                                           BY474x       Euroscarf
  SMy306        atg16::kan; ATG5-K57E,N84E-TAP-cyc1term-URA-tTEF                             BY474x       this study
  SMy308        atg16::kan; ATG5-TAP-cyc1term-URA-tTEF                                       BY474x       this study
  SMy342        Mat a; ATG5-TAP:URA3, atg19::KanMX, atg16::KanMX                             BY474x       this study
  SMy344        Mat a; ATG5-K57E,N84E-TAP:URA3, atg19::KanMX, atg16::KanMX                   BY474x       this study
  SMy346        atg19::KanMX, atg16::KanMX                                                   BY474x       this study
  SMy356        atg16::kan; pho13::kan; pho8∆60::His; ATG5-TAP-cyc1term-URA-tTEF             BY474x       this study
  SMy358        atg16::kan; pho13::kan; pho8∆60::His; ATG5-K57E,N84E-TAP-cyc1term-URA-tTEF   BY474x       this study
  yAB7          atg13::KanMX, ATG17-TEV-2xProtA-4xH3-5xHA:URA                                BY474x       ([@bib7])

All strains of *S.cerevisiae* S288C BY474x genetic background are derived from the diploid strain BY4743 and carry the following markers: his3∆1; leu2∆0; met15∆0; ura3∆0 except if stated otherwise. ATG5-TAP, ATG5-K57E,N84E-TAP, ATG16-TEV-2xProtA-4xH3-5xHA, ATG17-TEV-2xProtA-4xH3-5xHA strains were generated by homologous recombination of the tagged protein into the respective deletion strains. All other strains were generated by crossing of single strains.

Molecular dynamics simulations {#s4-22}
------------------------------

The initial coordinates of Atg5 (with a part of Atg16 bound to it) were obtained from the protein data bank (PDB) with identifier 2DYO ([@bib38]). The missing loops and atoms were modeled using the SWISS-MODEL server ([@bib2]; [@bib5]; [@bib6]). The final model contained residues 1--285 of Atg5 and 22--57 of Atg16 (numbered according to 2DYO).

The protonation states of the histidine residues were determined with the WHATIF server ([@bib64]). In order to capture the flexibility of the protein, molecular dynamics simulations were used to generate an ensemble of protein structures. These simulations, as well as the preparatory energy minimizations, were performed using GROMOS11 ([@bib57]) in combination with the Gromos force field 54a8 ([@bib52]). Initially, the Atg5-Atg16 complex was minimized in vacuum using steepest descent for 2000 steps. Subsequently, the complex was solvated in a rectangular box with 22,250 SPC water molecules ([@bib4]). The overall system was electrostatically neutral and therefore no ions were added. The solvent configurations were relaxed with another round of energy minimization where the solute atoms were position-restrained. Initial random velocities were drawn from a Maxwell-Boltzmann distribution at 50 K. Position restraints on the solute atoms were applied with an initial force constant of 2.5 × 10^4^ kJ mol^−1^ nm^−2^. With each step of equilibration performed at constant volume, the temperature was increased by 50 K, the force constant of the position restraints was reduced by a factor of 10 and the system was simulated for 20 ps. The final equilibration step was simulated for 40 ps at 298 K, without any position restraints. After these equilibration steps, the system was simulated for 1 ns at a constant temperature of 298 K using weak coupling at constant volume ([@bib3]). Two separate temperature baths were used for the solute and solvent and the relaxation time was set to 0.1 ps. All bond lengths were constrained using the SHAKE algorithm ([@bib55]) with a geometric accuracy of 1 × 10^−4^, which enabled the use of a two fs time step. The center of mass translation motion was removed every 1000 steps. A triple range cut-off scheme was used to calculate the non-bonded interactions and a pair-list was generated every fifth time step. Interactions within 0.8 nm were calculated at every time step, whereas the interactions between 0.8 and 1.4 nm were evaluated only when the pair-list was updated and kept constant at intermediate time steps. The interactions beyond 1.4 nm were approximated by a reaction field contribution, representing a homogeneous medium with a dielectric constant of 61, as appropriate for SPC water molecules ([@bib17]).

Docking {#s4-23}
-------

The molecular dynamics simulation, as described above, was used to obtain different configurations of the Atg5-Atg16 complex that could be used for docking. The initial configuration of Atg5-Atg16, as well as ten snapshots obtained from the simulation (sampled every 100 ps) were used to take the flexibility of the proteins into account during the subsequent docking procedure. The C-terminal peptide TWEEL of Atg19 was modeled with NH and COO^-^ termini. The NH terminus was chosen to represent the NH group of the peptide bond that would be present in the complete Atg19. AutoDock Vina ([@bib63]) was used to dock the peptide into the configurations of the Atg5-Atg16 complex. The exhaustiveness was set to 50 and the search space was defined such that the whole complex was searched. The peptide was completely flexible during the docking process, whereas the Atg5-Atg16 complex was kept rigid. For each of the configurations of Atg5-Atg16, the nine best poses of TWEEL were evaluated. The docking results were manually examined in order to discard any poses in which the Thr amino acid of the peptide was completely buried. These poses would not be possible with the complete Atg19 and are therefore not of interest. Three major interaction sites were found to be reoccurring in multiple snapshots of the Atg5-Atg16 complex. One of them involved residues of both Atg5 and Atg16. Since the focus of the present study was identification of the interactions of TWEEL with Atg5, this interaction site was no longer considered. For other binding sites, the hydrogen bonding patterns were examined for all the poses of the docked peptide in all of the configurations of Atg5-Atg16. Generally, several configurations of the peptide were found in each of the binding sites, but here we focused on the residues that were most prone to be involved in salt bridges or hydrogen bonds to the TWEEL peptide. The first binding site, which was also found in the initial configuration of the Atg5-Atg16 complex, was characterized by persistent salt bridges and hydrogen bonds between the glutamic acids of the peptide with K57 and K137. In the second binding site, the residues N84 and R208 were the ones that were most often involved hydrogen bonds and salt bridges with TWEEL.

Superposition of protein structures {#s4-24}
-----------------------------------

The Atg8 (PDB: 2ZPN, ([@bib47]) and Atg5 (PDB: 2DYO, ([@bib38]) structures were superposed by secondary-structure matching (SSM) ([@bib33]) using the Coot software ([@bib11]). The Atg8 molecule in complex with Atg19 AIM motif was superposed onto the two ubiquitin-like Atg5 bundles separately. The resulting shift of Atg19 AIM motif was depicted omitting the original Atg8 structure for clarity, indicating putative AIM binding pockets on Atg5.
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China

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Mechanism of cargo-directed Atg8 conjugation during selective autophagy\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Ivan Dikic as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers agreed that the authors present a mechanistic study describing cargo-stimulated Atg8 lipidation via Atg5/12/16 in biochemical reconstitution studies, providing a novel insight into the mechanism of autophagosome formation during selective autophagy. However, additional work is required to strengthen the manuscript to meet the standards for *eLife*. There was a general sense that much more clarity and caution needs to be applied to the description of experiments, results and, most importantly, conclusions.

Essential revisions:

1\) Bulk autophagy (starvation-induced non-selective autophagy) should be examined in the Atg5 mutant cells.

2\) The binding assays with the Atg5 mutants are largely in-vitro with purified components on beads. The interactions of these mutants in-vivo should be tested either by co-IP or perhaps some other method like proximity labeling, given that the effects on prApe1 processing are modest at best.

3\) Additional assays or replicates are necessary to demonstrate that the mapped residues in Atg5 (N84E, K57/N84E) are the key mediators of the Atg5-Atg19 interaction. Reviewers have a concern that reduced prApe1 processing in the Atg5 mutant strains presented in [Figure 5D](#fig5){ref-type="fig"} could be attributed to reduced loading of the gel (with quite large error across the replicate experiments) and also the in vitro lipidation assay in [Figure 5F](#fig5){ref-type="fig"} shows a minimal defect in Atg8 lipidation in the Atg5 double mutant.

4\) Several other adaptors such as p62 should be examined to investigate their interactions with Atg5-12-16 to demonstrate that the mechanism is not limited to yeast and has a broad impact.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Mechanism of cargo-directed Atg8 conjugation during selective autophagy\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Ivan Dikic (Senior editor), a Reviewing editor, and one reviewer.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) The authors should describe how the E102A mutation affects the function of Atg16. On the other hand, I also felt that newly added data using Atg16 mutants are less informative and thus can be omitted from the final version of the manuscript or transferred to figure supplements.

2\) [Figure 1C](#fig1){ref-type="fig"}: Since in the experiment using GST alone, a comparable amount of GST was not bound to the beads, this cannot serve as a control.

3\) [Figure 1E](#fig1){ref-type="fig"}: It is unclear whether the control strain (shown in the left lane) expressed 9xmyc-SUV alone or not. A strain expressing it should be examined.

4\) [Figure 1F](#fig1){ref-type="fig"}: A blot for anti-GFP should also be shown.

5\) [Figure 2A, C and E](#fig2){ref-type="fig"}: Images for GST proteins should also be added.

6\) [Figure 3A](#fig3){ref-type="fig"}: The label 407 is put at the wrong position.
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Author response

**\[...\]**

*Essential revisions:*

*1) Bulk autophagy (starvation-induced non-selective autophagy) should be examined in the Atg5 mutant cells.*

We have now characterized the Atg5 mutants much more thoroughly. In order to test the effect of the K57E,N84E mutations in Atg5 on starvation-induced bulk autophagy we conducted the GFP-Atg8 cleavage assay. The three replicates performed by us show no impairment of bulk autophagy in cells expressing the K57E,N84E mutant. Please see [Figure 5I](#fig5){ref-type="fig"} for a representative blot.

We also performed Pho8Δ60 activity assays in order to test the effect of the K57E, N84E and K57E, N84E mutations on bulk autophagy. The experiments performed show no difference in activity of the Pho8Δ60 enzyme between wild type Atg5 and the mutants. Please refer to [Figure 5J, K](#fig5){ref-type="fig"} for quantifications. Thus, our data strongly suggest that the K57E, N84E mutant does not affect bulk autophagy.

*2) The binding assays with the Atg5 mutants are largely in-vitro with purified components on beads. The interactions of these mutants in-vivo should be tested either by co-IP or perhaps some other method like proximity labeling, given that the effects on prApe1 processing are modest at best.*

We have conducted co-IP experiments with Atg5 K57E, N84E and a representative blot of such an experiment is shown in [Figure 5F](#fig5){ref-type="fig"}. In particular, we found that the K57E,N84E mutation resulted in a robust decrease in the interaction with Atg19. In order to corroborate this result, we went a step further and investigated the Atg5 -- Atg19 interaction in context of the Atg16 E102A mutation. This mutation is based on a previous finding by Juris et al., 2015, EMBOJ (PMID: 25691244) reporting that Atg21 recruits Atg16 to the PAS during the Cvt pathway and that the E102A mutation in Atg16 impairs the Atg16 -- Atg21 interaction. We reasoned that this interaction may indirectly stabilize the Atg12\~Atg5-Atg16 -- Atg19 complex. Indeed, we found an even further decrease of the Atg12\~Atg5-Atg16 -- Atg19 interaction in context of the Atg16 E102A mutation ([Figure 5F](#fig5){ref-type="fig"}).

*3) Additional assays or replicates are necessary to demonstrate that the mapped residues in Atg5 (N84E, K57/N84E) are the key mediators of the Atg5-Atg19 interaction. Reviewers have a concern that reduced prApe1 processing in the Atg5 mutant strains presented in [Figure 5D](#fig5){ref-type="fig"} could be attributed to reduced loading of the gel (with quite large error across the replicate experiments) and also the* in vitro *lipidation assay in [Figure 5F](#fig5){ref-type="fig"} shows a minimal defect in Atg8 lipidation in the Atg5 double mutant.*

We have replaced the blot shown in [Figure 5D](#fig5){ref-type="fig"} with a technically better blot (see [Figure 5G](#fig5){ref-type="fig"}). We also conducted additional prApe1 processing assays that confirm the impairment of prApe1 processing by the Atg5 K57E, N84E mutation ([Figure 5H](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). This included the analysis of the prApe1 transport in context of the Atg16 D101A, E102E mutation, which was reported to reduce the recruitment of Atg12\~Atg5-Atg16 by Atg21 to the PAS (please see Juris et al., 2015, EMBOJ (PMID: 25691244) and our reply to your comment number 2).

Moreover, we have conducted additional in vitro lipidation assays and quantified them. The graph of this quantification has been inserted in [Figure 5E](#fig5){ref-type="fig"} and it shows that the Atg5 mutants do not display significant defects in promoting Atg8\~PE conjugation. A more representative gel of the in vitro conjugation assay has been inserted in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} in place of the previous one (right panel).

*4) Several other adaptors such as p62 should be examined to investigate their interactions with Atg5-12-16 to demonstrate that the mechanism is not limited to yeast and has a broad impact.*

In our previous version we could already demonstrate that the human ATG5 coprecipitates p62. Upon request of the reviewers we have now extended this analysis and demonstrate that also the Optineurin and NDP52 cargo receptors co-precipitate with ATG5 (please see [Figure 1F-H](#fig1){ref-type="fig"}). Thus the interaction of cargo receptors with components of the Atg12\~Atg5-Atg16 appears to be a more general phenomenon. At this point we do not know if this interaction is direct and in order to thoroughly investigate this interaction we would have to have the recombinant human Atg12\~Atg5-Atg16 complex in our hands, which is currently not the case.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:*

*1) The authors should describe how the E102A mutation affects the function of Atg16. On the other hand, I also felt that newly added data using Atg16 mutants are less informative and thus can be omitted from the final version of the manuscript or transferred to figure supplements.*

Thank you for raising this point. We have now moved the main experiments showing data obtained with the Atg16 mutant to the figure supplements ([Figure 5---figure supplements 3](#fig5s3){ref-type="fig"} and [4](#fig5s4){ref-type="fig"}). We have decided to keep the IP experiments including the Atg16 E102A mutant in the main figure ([Figure 5F](#fig5){ref-type="fig"}) since it corroborates the interaction of Atg5 with Atg19 in vivo and suggests that there may be an additional recruitment of the Atg12\~Atg5-Atg16 to the PAS by Atg21.

*2) [Figure 1C](#fig1){ref-type="fig"}: Since in the experiment using GST alone, a comparable amount of GST was not bound to the beads, this cannot serve as a control.*

Thank you for raising this point. We have now moved the main experiments showing data obtained with the Atg16 mutant to the figure supplements ([Figure 5---figure supplements 3](#fig5s3){ref-type="fig"} and [4](#fig5s4){ref-type="fig"}). We have decided to keep the IP experiments including the Atg16 E102A mutant in the main figure ([Figure 5F](#fig5){ref-type="fig"}) since it corroborates the interaction of Atg5 with Atg19 in vivo and suggests that there may be an additional recruitment of the Atg12\~Atg5-Atg16 to the PAS by Atg21.

*3) [Figure 1E](#fig1){ref-type="fig"}: It is unclear whether the control strain (shown in the left lane) expressed 9xmyc-SUV alone or not. A strain expressing it should be examined.*

The control you are referring to was conducted in the study that originally reported the technique (Brezovich, Schuschnig, Ammerer, Kraft, 2015, Yeast). In particular, [Figure 2](#fig2){ref-type="fig"} of this study shows that overexpression of a myc-tagged methyltransferase from a Gal promoter does not result in unspecific methylation of the H3 tail. Since the methyltransferase fused to Atg19 is expressed from the Atg19 promoter and thus at much lower levels compared to Gal promoter driven expression, we have not included this control in our experiments. We have added an explanatory sentence to the text (Results section).

*4) [Figure 1F](#fig1){ref-type="fig"}: A blot for anti-GFP should also be shown.*

We have now added anti-GFP blots for this experiment to [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.

*5) [Figure 2A, C and E](#fig2){ref-type="fig"}: Images for GST proteins should also be added.*

We have now added images of the GST proteins to [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}.

*6) [Figure 3A](#fig3){ref-type="fig"}: The label 407 is put at the wrong position.*

Thank you for pointing this out. This mistake has been corrected.
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